1
|
Dos Santos KC, Guedes PEB, Albuquerque GR, de Jesus AV, da Paixão Sevá A, de Oliveira JTS, de Carvalho Teixeira JB, Bitar TV, Harvey TV, Ramos SNS, Barufi FB, de Almeida Borges F, Carlos RSA. Efficacy of monthly treatment with oral fluralaner (Bravecto ® 1-Month) against Tunga penetrans in dogs in Brazil: a randomized, double-blind, controlled field study. Parasit Vectors 2024; 17:197. [PMID: 38685048 PMCID: PMC11059606 DOI: 10.1186/s13071-024-06272-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2024] [Accepted: 04/07/2024] [Indexed: 05/02/2024] Open
Abstract
BACKGROUND Tungiasis is a neglected tropical disease caused by the adult female sand flea (Tunga penetrans). Dogs are considered important reservoirs of T. penetrans in Brazil. The aim of this study was to determine the monthly insecticidal efficacy of a single oral administration of fluralaner at a dose of 10-18 mg/kg (Bravecto® 1-Month, also registered as Defenza® in some countries; MSD Animal Health) in dogs naturally infested with T. penetrans. METHODS This clinical trial was conducted in a rural community located in Ilhéus, Bahia, Brazil. A total of 64 dogs were selected and distributed in a completely randomized design between a treated group (TG) that received one single dose of Bravecto® 1-Month (Defenza®) and a negative control group (CG) that received no treatment. Each group was composed of 32 dogs. The evaluations took place on days 0, 7 ± 2, 14 ± 2, 21 ± 2, 28 ± 2, 35 ± 2, and 42 ± 2 post treatment, in which the dogs were inspected to evaluate the infestation stage and classify lesions associated with tungiasis. The primary efficacy was determined from the percentage of treated dogs free of fleas (stage II and III lesions) after administration of the formulation at each evaluation time. Secondary efficacy was based on the number of active lesions (stages II and III) in each group at each evaluation time. The clinical condition of the animals was defined based on the Severity Score for Acute Dog Tungiasis (SCADT), which is related to the number and severity of lesions. RESULTS The primary efficacy of the product was greater than 95.0% from days 7 to 21 and reached 100.0% between days 28 and 42, with a significant association between treatment and infestation decline (P < 0.025) between days 7 and 42. Secondary drug efficacy was greater than 99.9% from days 7 to 21, reaching 100.0% between days 28 and 42 (P < 0.05). The treated dogs also scored lower on the SCADT than the control animals did during the entire clinical evaluation period (P < 0.05). CONCLUSIONS A single administration of Bravecto® 1-Month (Defenza®) was effective in eliminating Tunga penetrans infestations, as well as in preventing parasitism for at least 42 days after treatment.
Collapse
Affiliation(s)
- Katharine Costa Dos Santos
- Department of Agricultural and Environmental Sciences, Postgraduate Program in Animal Science, UESC, State University of Santa Cruz, Rod. Jorge Amado Km 16-Salobrinho, Ilhéus, Bahia, 45662-900, Brazil
| | - Paula Elisa Brandão Guedes
- Department of Agricultural and Environmental Sciences, Postgraduate Program in Animal Science, UESC, State University of Santa Cruz, Rod. Jorge Amado Km 16-Salobrinho, Ilhéus, Bahia, 45662-900, Brazil
| | - George Rêgo Albuquerque
- Department of Agricultural and Environmental Sciences, Postgraduate Program in Animal Science, UESC, State University of Santa Cruz, Rod. Jorge Amado Km 16-Salobrinho, Ilhéus, Bahia, 45662-900, Brazil
| | - Anderson Vieira de Jesus
- Department of Agricultural and Environmental Sciences, Postgraduate Program in Animal Science, UESC, State University of Santa Cruz, Rod. Jorge Amado Km 16-Salobrinho, Ilhéus, Bahia, 45662-900, Brazil
| | - Anaiá da Paixão Sevá
- Department of Agricultural and Environmental Sciences, Postgraduate Program in Animal Science, UESC, State University of Santa Cruz, Rod. Jorge Amado Km 16-Salobrinho, Ilhéus, Bahia, 45662-900, Brazil
| | - Joana Thaisa Santos de Oliveira
- Department of Agricultural and Environmental Sciences, Postgraduate Program in Animal Science, UESC, State University of Santa Cruz, Rod. Jorge Amado Km 16-Salobrinho, Ilhéus, Bahia, 45662-900, Brazil
| | - Jamille Bispo de Carvalho Teixeira
- Department of Agricultural and Environmental Sciences, Postgraduate Program in Animal Science, UESC, State University of Santa Cruz, Rod. Jorge Amado Km 16-Salobrinho, Ilhéus, Bahia, 45662-900, Brazil
| | - Thammy Vieira Bitar
- Department of Agricultural and Environmental Sciences, Postgraduate Program in Animal Science, UESC, State University of Santa Cruz, Rod. Jorge Amado Km 16-Salobrinho, Ilhéus, Bahia, 45662-900, Brazil
| | | | - Sofia Nadir Sanches Ramos
- MSD, Merck & Co Animal Health, Avenida Doutor Chucri Zaidan, 296, 12º Andar, São Paulo, 04583-110, Brazil
| | - Francisco Bonomi Barufi
- MSD, Merck & Co Animal Health, Avenida Doutor Chucri Zaidan, 296, 12º Andar, São Paulo, 04583-110, Brazil
| | - Fernando de Almeida Borges
- Faculty of Veterinary Medicine and Zootechnics, UFMS, Federal University of Mato Grosso Do Sul, Campo Grande, Mato Grosso Do Sul, Brazil
| | - Renata Santiago Alberto Carlos
- Department of Agricultural and Environmental Sciences, Postgraduate Program in Animal Science, UESC, State University of Santa Cruz, Rod. Jorge Amado Km 16-Salobrinho, Ilhéus, Bahia, 45662-900, Brazil.
| |
Collapse
|
2
|
Alcântara JA, de Araújo FSA, da Costa Paz A, Alencar RM, de Albuquerque Caldas BY, Godoy RSM, Lacerda MVG, de Melo GC, Monteiro WM, de Souza Sampaio V, Secundino NFC, Duarte APM, Santana RAG, Pimenta PFP. Effect of fluralaner on the biology, survival, and reproductive fitness of the neotropical malaria vector Anopheles aquasalis. Malar J 2023; 22:337. [PMID: 37936198 PMCID: PMC10631211 DOI: 10.1186/s12936-023-04767-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2023] [Accepted: 10/24/2023] [Indexed: 11/09/2023] Open
Abstract
BACKGROUND Reducing mosquito abundance or interfering with its ability to support the parasite cycle can help to interrupt malaria in areas of significant risk of malaria transmission. Fluralaner is a safe and effective drug for veterinary use indicated for the treatment against fleas and ticks which acts as an antagonist of chloride ion channels mediated by γ-aminobutyric acid (GABA), preventing the entry of these ions into the postsynaptic neuron, leading to hyperexcitability of the postsynaptic neuron of the central nervous system of arthropods. Fluralaner demonstrated insecticidal activity against different insect species. METHODS The study aimed to evaluate the effects of fluralaner on the biology, survival, and reproductive fitness of Anopheles aquasalis. The following lethal concentrations (LC) were determined for An. aquasalis: LC5 = 0.511 µM; LC25 = 1.625 µM; LC50 = 3.237 µM. RESULTS A significant decrease (P < 0.001) was evident in the number of eggs, larvae, and pupae in the group exposed to a sublethal dose of fluralaner when compared to a control group (without the drug). Using blood from dogs after administration of fluralaner, it was observed that the drug causes 100% mortality in An. aquasalis in less than 24 h after feeding; this effect remains even after 90 days in all samples. DISCUSSION Fluralaner showed the same result for up to 60 days, and after that, there was a slight reduction in its effect, evidenced by a decrease in the percentage of dead females; however, still significant when compared to the control group. CONCLUSION Fluralaner affects the biology and reduction of survival in An. aquasalis in a lasting and prolonged period, and its fecundity with lower dosages, is a strong candidate for controlling disease vectors.
Collapse
Affiliation(s)
- João Arthur Alcântara
- Programa de Pós-graduação em Medicina Tropical-Universidade do Estado do Amazonas/Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (PPGM-UEA/FMT-HVD), Manaus, Brazil
- Departamento de Ensino e Pesquisa-Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (DENPE/FMT-HVD), Manaus, Brazil
| | - Francys Sayara Andrade de Araújo
- Programa de Pós-graduação em Medicina Tropical-Universidade do Estado do Amazonas/Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (PPGM-UEA/FMT-HVD), Manaus, Brazil
- Departamento de Ensino e Pesquisa-Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (DENPE/FMT-HVD), Manaus, Brazil
| | - Andréia da Costa Paz
- Programa de Pós-graduação em Medicina Tropical-Universidade do Estado do Amazonas/Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (PPGM-UEA/FMT-HVD), Manaus, Brazil
- Departamento de Ensino e Pesquisa-Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (DENPE/FMT-HVD), Manaus, Brazil
| | - Rodrigo Maciel Alencar
- Programa de Pós-graduação em Medicina Tropical-Universidade do Estado do Amazonas/Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (PPGM-UEA/FMT-HVD), Manaus, Brazil
- Departamento de Ensino e Pesquisa-Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (DENPE/FMT-HVD), Manaus, Brazil
| | | | - Raquel Soares Maia Godoy
- Programa de Pós-Graduação Em Ciências da Saúde, FIOCRUZ-Belo Horizonte, Belo Horizonte, Minas Gerais, Brazil
- Instituto René Rachou-Fundação Oswaldo Cruz-(IRR-Fiocruz Minas), Belo Horizonte, Brazil
| | - Marcus Vinicius Guimarães Lacerda
- Programa de Pós-graduação em Medicina Tropical-Universidade do Estado do Amazonas/Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (PPGM-UEA/FMT-HVD), Manaus, Brazil
- Departamento de Ensino e Pesquisa-Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (DENPE/FMT-HVD), Manaus, Brazil
- Instituto Leônidas e Maria Deane - Fundação Oswaldo Cruz - (ILMD - Fiocruz Amazônia), Manaus, Brazil
- University of Texas Medical Branch (UTMB), Galveston, USA
| | - Gisely Cardoso de Melo
- Programa de Pós-graduação em Medicina Tropical-Universidade do Estado do Amazonas/Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (PPGM-UEA/FMT-HVD), Manaus, Brazil
- Departamento de Ensino e Pesquisa-Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (DENPE/FMT-HVD), Manaus, Brazil
| | - Wuelton Marcelo Monteiro
- Programa de Pós-graduação em Medicina Tropical-Universidade do Estado do Amazonas/Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (PPGM-UEA/FMT-HVD), Manaus, Brazil
- Departamento de Ensino e Pesquisa-Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (DENPE/FMT-HVD), Manaus, Brazil
| | - Vanderson de Souza Sampaio
- Programa de Pós-graduação em Medicina Tropical-Universidade do Estado do Amazonas/Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (PPGM-UEA/FMT-HVD), Manaus, Brazil
- Departamento de Ensino e Pesquisa-Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (DENPE/FMT-HVD), Manaus, Brazil
| | - Nágila Francinete Costa Secundino
- Programa de Pós-graduação em Medicina Tropical-Universidade do Estado do Amazonas/Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (PPGM-UEA/FMT-HVD), Manaus, Brazil
- Departamento de Ensino e Pesquisa-Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (DENPE/FMT-HVD), Manaus, Brazil
- Programa de Pós-Graduação Em Ciências da Saúde, FIOCRUZ-Belo Horizonte, Belo Horizonte, Minas Gerais, Brazil
- Instituto René Rachou-Fundação Oswaldo Cruz-(IRR-Fiocruz Minas), Belo Horizonte, Brazil
| | - Ana Paula Marques Duarte
- Programa de Pós-graduação em Medicina Tropical-Universidade do Estado do Amazonas/Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (PPGM-UEA/FMT-HVD), Manaus, Brazil
- Departamento de Ensino e Pesquisa-Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (DENPE/FMT-HVD), Manaus, Brazil
- Instituto René Rachou-Fundação Oswaldo Cruz-(IRR-Fiocruz Minas), Belo Horizonte, Brazil
| | - Rosa Amélia Gonçalves Santana
- Departamento de Ensino e Pesquisa-Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (DENPE/FMT-HVD), Manaus, Brazil
- Instituto Leônidas e Maria Deane - Fundação Oswaldo Cruz - (ILMD - Fiocruz Amazônia), Manaus, Brazil
| | - Paulo Filemon Paolucci Pimenta
- Programa de Pós-graduação em Medicina Tropical-Universidade do Estado do Amazonas/Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (PPGM-UEA/FMT-HVD), Manaus, Brazil.
- Departamento de Ensino e Pesquisa-Fundação de Medicina Tropical Dr. Heitor Vieira Dourado (DENPE/FMT-HVD), Manaus, Brazil.
- Programa de Pós-Graduação Em Ciências da Saúde, FIOCRUZ-Belo Horizonte, Belo Horizonte, Minas Gerais, Brazil.
- Instituto René Rachou-Fundação Oswaldo Cruz-(IRR-Fiocruz Minas), Belo Horizonte, Brazil.
| |
Collapse
|
3
|
da Costa AJ, de Souza Martins JR, de Almeida Borges F, Vettorato LF, Barufi FB, de Oliveira Arriero Amaral H, Abujamra LC, de Castro Rodrigues D, Zanetti Lopes WD. First report of the efficacy of a fluralaner-based pour-on product (Exzolt® 5%) against ectoparasites infesting cattle in Brazil. Parasit Vectors 2023; 16:336. [PMID: 37752574 PMCID: PMC10523720 DOI: 10.1186/s13071-023-05934-7] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2023] [Accepted: 08/15/2023] [Indexed: 09/28/2023] Open
Abstract
BACKGROUND This study describes the effectiveness of a novel active pharmaceutical ingredient, fluralaner (isoxazoline class), against important ectoparasites infesting cattle in Brazil. METHODS A total of 13 studies involving a 5% fluralaner-based pour-on formulation (Exzolt 5%; further referred to as Exzolt) were conducted. Specifically, the effectiveness of this formulation was studied against Rhipicephalus microplus (6 studies), Cochliomyia hominivorax larvae (4 studies), Dermatobia hominis larvae (1 study) and Haematobia irritans flies (2 studies). RESULTS The therapeutic efficacy of Exzolt was found to exceed 98% at 4 days post treatment (DPT), while persistent efficacy (> 90% efficacy) against repeated infestations of R. microplus was observed for up to 79 DPT. In field studies, ≥ 98% therapeutic efficacy was demonstrated at all study sites by 7 DPT, and a persistent efficacy (> 90% efficacy) was observed for 42, 49 or 56 DPT. Exzolt prevented C. hominivorax eggs from developing to the larval stage, thus mitigating the development of myiasis in cattle naturally and artificially infested with this screworm. The efficacy of Exzolt against D. hominis larvae was 98% at 3 DPT, while persistent efficacy (> 90% effectiveness) was found to last for up to 70 DPT. Against H. irritans, Exzolt showed therapeutic efficacy (≥ 90%) within the first day of treatment at both study sites, while persistent efficacy (≥ 90%) was observed for 7 DPT at one site and for 21 DPT at the other site. CONCLUSIONS Overall, the results from these studies confirm that Exzolt is therapeutically efficacious against the most important ectoparasites infesting cattle in Brazil. The novel active pharmaceutical ingredient, fluralaner, provides a new treatment option for farmers to control cattle ectoparasites, especially where there is resistance to other chemical classes. In addition, an effective control of ectoparasites will improve overall cattle health and well-being as well as production.
Collapse
Affiliation(s)
- Alvimar José da Costa
- Faculdade de Ciências Agrárias e Veterinárias, Universidade Estadual Paulista, Jaboticabal, São Paulo, Brazil
| | | | - Fernando de Almeida Borges
- Departamento de Medicina Veterinária, Universidade Federal do Mato Grosso Do Sul, Campo Grande, Mato Grosso do Sul, Brazil
| | | | | | | | | | - Daniel de Castro Rodrigues
- MSD Saúde Animal, São Paulo, Brazil
- Centro de Parasitologia Veterinária, Universidade Federal de Goiás, Goiânia, Goiás, Brazil
| | | |
Collapse
|
4
|
Ireland EM, Heller J, Leister EM, Padula AM. Reduced incidence of tick paralysis cases in dogs and cats at two emergency clinics in South-East Queensland since 2015: new generation prophylactics as possible explanatory variables. Aust Vet J 2023; 101:356-365. [PMID: 37503789 DOI: 10.1111/avj.13269] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2022] [Revised: 02/16/2023] [Accepted: 07/08/2023] [Indexed: 07/29/2023]
Abstract
INTRODUCTION This study aimed to determine the incidence of canine and feline tick paralysis cases presenting to two veterinary emergency hospitals before and after the introduction of new generation prophylactic acaricides. METHODS This was a retrospective study, investigating the number of tick paralysis cases presenting to two emergency and critical care veterinary hospitals in South-East Queensland, from 2008 to 2021. A total of 10,914 dogs and 3696 cats were included over the course of the study. To assess if the introduction of new generation prophylactics in 2015 has coincided with any variation in case numbers, data for each species were analysed graphically and numerically in the first instance, then interrupted time series analyses were performed for the dog and cat data independently. RESULTS Accounting for seasonal and climatic variation, we estimated a 54.8% reduction in dog (95% CI 45.3%-62.7%) and 44% reduction in cat (95% CI 19.5%-46%) tick paralysis cases presenting to these two clinics. This reduction corresponded with the timing of new generation prophylactic agents being introduced, including isoxazolines and imidacloprid/flumethrin impregnated collars. CONCLUSION In the population studied, a significant reduction in the incidence of tick paralysis cases treated by veterinarians has occurred from 2015 onwards and was found to be associated with the timing of the release of new generation acaricidal products.
Collapse
Affiliation(s)
- E M Ireland
- Animal Emergency Service, Underwood, Australia
- Pet Intensive Care Unit, Underwood, Australia
| | - J Heller
- Heller Consulting, Wagga Wagga, NSW, Australia
- Gulbali Research Institute, Charles Sturt University, Wagga Wagga, NSW, Australia
- School of Agricultural, Environmental and Veterinary Sciences, Charles Sturt University, Wagga Wagga, NSW, Australia
| | - E M Leister
- Pet Intensive Care Unit, Underwood, Australia
| | - A M Padula
- Padula Serums, Bairsndale, VIC, Australia
- Australian Venom Research Unit, University of Melbourne, Parkville, VIC, Australia
| |
Collapse
|
5
|
Fereydooni S, Arfaee F, Youssefi MR, Gharib FZ, Tabari MA. In vitro toxicity of combination of amitraz and carvacrol on Demodex canis. Open Vet J 2023; 13:894-902. [PMID: 37614730 PMCID: PMC10443819 DOI: 10.5455/ovj.2023.v13.i7.11] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2023] [Accepted: 06/25/2023] [Indexed: 08/25/2023] Open
Abstract
Background Canine generalized demodicosis is an inflammatory skin disease, which usually has time-consuming and frustrating treatments. Aim The present study aimed to evaluate the acaricidal activity of carvacrol as a green drug and a combination of carvacrol and amitraz on Demodex canis mites and investigate mites' survival lifetime. Methods Mite samples were collected from a dog affected by demodicosis and had been diagnosed with deep skin scrapings. The motility of mites was examined by using optical microscopy. Samples were tested with 5% of carvacrol, the combination of Carvacrol 5% + Amitraz 0.05%, Amitraz 0.05% as a positive control, and mineral oil as a negative control. The interval time between the adding the test solutions and the moment the last mite ceased was defined as the survival time in the samples and the killing times of mites in each group were compared with each other. Results It was determined that after administration of a 5% concentration of carvacrol, lethal effects were faster than the combination solution of Carvacrol 5% + Amitraz 0.05%, and the survival times in the control groups were longer than in both treatment groups. Conclusion Carvacrol, as one of the most important bioactive terpenes, had the most effective in vitro miticidal activity, and it seems that carvacrol alone or in combination with amitraz can be suggested as a possible therapy in the treatment of canine demodicosis.
Collapse
Affiliation(s)
- Sina Fereydooni
- Department of Clinical Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran
| | - Farnoosh Arfaee
- Department of Clinical Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran
| | - Mohammad Reza Youssefi
- Department of Veterinary Parasitology, Babol Branch, Islamic Azad University, Babol, Iran
| | - Fatemeh Zahra Gharib
- Department of Veterinary Clinical Sciences, Babol Branch, Islamic Azad University, Babol, Iran
| | | |
Collapse
|
6
|
Duncan K, Barrett AW, Little SE, Sundstrom KD, Guerino F. Fluralaner (Bravecto ®) treatment kills Aedes aegypti after feeding on Dirofilaria immitis-infected dogs. Parasit Vectors 2023; 16:208. [PMID: 37340454 DOI: 10.1186/s13071-023-05819-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2023] [Accepted: 05/26/2023] [Indexed: 06/22/2023] Open
Abstract
BACKGROUND Transmission of canine heartworm (Dirofilaria immitis) from infected to naïve dogs is dependent on successful mosquito feeding and survival. METHODS To determine whether treating heartworm-infected dogs with fluralaner (Bravecto®) limits the survival of infected mosquitoes, and potentially the transmission of D. immitis, we allowed female mosquitoes to feed on microfilaremic dogs and evaluated mosquito survival and infection with D. immitis. Eight dogs were experimentally infected with D. immitis. On day 0 (~ 11 months post-infection), four microfilaremic dogs were treated with fluralaner according to label directions while the other four were non-treated controls. Mosquitoes (Aedes aegypti Liverpool) were allowed to feed on each dog on days -7, 2, 30, 56, and 84. Fed mosquitoes were collected, and the number of live mosquitoes determined at 6 h, 24 h, 48 h, and 72 h post-feeding. Surviving mosquitoes held for 2 weeks were dissected to confirm third-stage D. immitis larvae; PCR (12S rRNA gene) was performed post-dissection to identify D. immitis in mosquitoes. RESULTS Prior to treatment, 98.4%, 85.1%, 60.7%, and 40.3% of mosquitoes fed on microfilaremic dogs were alive at 6 h, 24 h, 48 h, and 72 h post-feeding, respectively. Similarly, mosquitoes fed on microfilaremic, non-treated dogs were alive 6 h post-feeding (98.5-100%) throughout the study. In contrast, mosquitoes fed on fluralaner-treated dogs 2 days after treatment were dead or severely moribund by 6 h post-feeding. At 30 and 56 days post-treatment, > 99% of mosquitoes fed on treated dogs were dead by 24 h. At 84 days post-treatment, 98.4% of mosquitoes fed on treated dogs were dead by 24 h. Before treatment, third-stage larvae of D. immitis were recovered from 15.5% of Ae. aegypti 2 weeks after feeding, and 72.4% were positive for D. immitis by PCR. Similarly, 17.7% of mosquitoes fed on non-treated dogs had D. immitis third-stage larvae 2 weeks after feeding, and 88.2% were positive by PCR. Five mosquitoes fed on fluralaner-treated dogs survived 2 weeks post-feeding, and 4/5 were from day 84. None had third-stage larvae at dissection, and all were PCR-negative. CONCLUSION The data indicate that fluralaner treatment of dogs kills mosquitoes and thus would be expected to reduce transmission of heartworm in the surrounding community.
Collapse
Affiliation(s)
- Kathryn Duncan
- Merck Animal Health, Rahway, NJ, USA.
- College of Veterinary Medicine, Oklahoma State University, Stillwater, OK, USA.
| | | | - Susan E Little
- College of Veterinary Medicine, Oklahoma State University, Stillwater, OK, USA
| | - Kellee D Sundstrom
- College of Veterinary Medicine, Oklahoma State University, Stillwater, OK, USA
| | | |
Collapse
|
7
|
Evans CC, Normile D, Gamble S, Guerino F, Dzimianski MT, Moorhead AR. Treatment of dogs with Bravecto ® (fluralaner) reduces mosquito survival and fecundity. Parasit Vectors 2023; 16:147. [PMID: 37106394 PMCID: PMC10142166 DOI: 10.1186/s13071-023-05682-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2022] [Accepted: 01/21/2023] [Indexed: 04/29/2023] Open
Abstract
BACKGROUND Mosquitoes serve as the vector of canine heartworm (Dirofilaria immitis), which represents a significant and persistent threat to canine health. A reduction in the longevity and/or reproductive success of mosquitoes that take a blood meal from fluralaner-treated dogs may consequently reduce the local transmission of heartworm and prevent new infections. A novel secondary effect of an oral formulation of the ectoparasiticide fluralaner (Bravecto®) against a laboratory strain of the mosquito Aedes aegypti, a potential major vector of canine heartworm, was investigated in this study. METHODS Six dogs were administered a single dose of fluralaner orally in the form of Bravecto® Chews (at the labeled fluralaner dose of 25 mg/kg body weight), while six control dogs received no treatment. Mosquitoes were fed on blood that was collected from each dog prior to treatment and weekly for 15 weeks post-treatment to assess the continued effects of fluralaner as its serum level decreased. Mosquito fitness was assessed by three parameters: rate of successful blood-feeding, survival, and egg laying. RESULTS Successful blood-feeding rate was similar between control and treatment groups. In the fluralaner treatment, mosquito survival was significantly reduced within the first 24 h after blood-feeding, for the first 12 weeks post-treatment of the dogs (efficacy range = 33.2-73.3%). Survival of mosquitoes up until a potentially heartworm-infective timepoint (14 days post-blood-feeding) was significantly reduced in the fluralaner-treated group at several timepoints (1, 2, 5, 11, 12, 13, 14, and 15 weeks post-treatment; efficacy range = 49.4-91.4%), but was less consistently reduced at the other timepoints. Egg laying by mosquitoes was almost completely suppressed for the first 13 weeks following treatment of the dogs with fluralaner (treatment efficacy ≥ 99.8%). CONCLUSIONS Mosquitoes fed blood from fluralaner-treated dogs experienced a significant reduction in survival and fecundity. These findings support the potential for a reduction in heartworm transmission directly by lethal effects on the vector and indirectly through a reduction of the local vector population when mosquitoes are exposed to animals treated with fluralaner.
Collapse
Affiliation(s)
- Christopher Charles Evans
- Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA, USA.
| | | | | | | | - Michael T Dzimianski
- Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA, USA
| | - Andrew Riddell Moorhead
- Department of Infectious Diseases, College of Veterinary Medicine, University of Georgia, Athens, GA, USA
| |
Collapse
|
8
|
Huggins LG, Koehler AV, Gasser RB, Traub RJ. Advanced approaches for the diagnosis and chemoprevention of canine vector-borne pathogens and parasites-Implications for the Asia-Pacific region and beyond. ADVANCES IN PARASITOLOGY 2023; 120:1-85. [PMID: 36948727 DOI: 10.1016/bs.apar.2022.12.001] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
Vector-borne pathogens (VBPs) of canines are a diverse range of infectious agents, including viruses, bacteria, protozoa and multicellular parasites, that are pernicious and potentially lethal to their hosts. Dogs across the globe are afflicted by canine VBPs, but the range of different ectoparasites and the VBPs that they transmit predominate in tropical regions. Countries within the Asia-Pacific have had limited prior research dedicated to exploring the epidemiology of canine VBPs, whilst the few studies that have been conducted show VBP prevalence to be high, with significant impacts on dog health. Moreover, such impacts are not restricted to dogs, as some canine VBPs are zoonotic. We reviewed the status of canine VBPs in the Asia-Pacific, with particular focus on nations in the tropics, whilst also investigating the history of VBP diagnosis and examining recent progress in the field, including advanced molecular methods, such as next-generation sequencing (NGS). These tools are rapidly changing the way parasites are detected and discovered, demonstrating a sensitivity equal to, or exceeding that of, conventional molecular diagnostics. We also provide a background to the armoury of chemopreventive products available for protecting dogs from VBP. Here, field-based research within high VBP pressure environments has underscored the importance of ectoparasiticide mode of action on their overall efficacy. The future of canine VBP diagnosis and prevention at a global level is also explored, highlighting how evolving portable sequencing technologies may permit diagnosis at point-of-care, whilst further research into chemopreventives will be essential if VBP transmission is to be effectively controlled.
Collapse
Affiliation(s)
- Lucas G Huggins
- Faculty of Veterinary and Agricultural Sciences, Melbourne Veterinary School, The University of Melbourne, Parkville, VIC, Australia.
| | - Anson V Koehler
- Faculty of Veterinary and Agricultural Sciences, Melbourne Veterinary School, The University of Melbourne, Parkville, VIC, Australia
| | - Robin B Gasser
- Faculty of Veterinary and Agricultural Sciences, Melbourne Veterinary School, The University of Melbourne, Parkville, VIC, Australia
| | - Rebecca J Traub
- Faculty of Veterinary and Agricultural Sciences, Melbourne Veterinary School, The University of Melbourne, Parkville, VIC, Australia
| |
Collapse
|
9
|
Huang Q, Jia Z, Wu S, Liu F, Wang Y, Song G, Chang X, Zhao C. The acute toxicity, mechanism, bioconcentration and elimination of fluxametamide on zebrafish (Danio rerio). ENVIRONMENTAL POLLUTION (BARKING, ESSEX : 1987) 2023; 317:120808. [PMID: 36464115 DOI: 10.1016/j.envpol.2022.120808] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/17/2022] [Revised: 11/24/2022] [Accepted: 12/01/2022] [Indexed: 06/17/2023]
Abstract
Fluxametamide is a completely novel and the first isoxazoline insecticide used to control agricultural pests and has high insecticidal properties. To expand its usage in the paddy field, its potential toxicological effects on fish are necessary to make clear. In this study, the acute toxicity, bioconcentration and elimination of fluxametamide to zebrafish Danio rerio, and the action mode of it on the heteromeric Drα1β2Sγ2 and Drα1β2S GABA receptor was respectively determined by HPLC and two-electrode voltage clamp technique. Fluxametamide exhibited high toxicity to D. rerio, whereas slightly inhibited the GABA-stimulated current of Drα1β2Sγ2 or Drα1β2S. It showed high bioconcentration level in D. rerio at 0.0314 mg L-1 and 0.157 mg L-1, with bioconcentration factors at steady state of 1491.55 and 2875.28, respectively. The concentration of fluxametamide in D. rerio rapidly decreased from 47.84 ± 0.12 to 9.77 ± 1.13 mg kg-1 in 0.0314 mg L-1 or from 393.19 ± 0.46 to 46.93 ± 2.88 mg kg-1 in 0.157 mg L-1 within 10 days, and steadily kept at a low level after 18 days. In conclusion, fluxametamide has highly acute toxicity to D. rerio, and might induce high bioconcentration in a short time. As we know, this is the first report to provide a theoretical basis for evaluating the potential risk of fluxametamide on fish, and guidance for the application of fluxametamide.
Collapse
Affiliation(s)
- Qiutang Huang
- Key Laboratory of Integrated Pest Management on Crops in East China, Ministry of Agriculture, College of Plant Protection, Nanjing Agricultural University, Nanjing, 210095, PR China.
| | - Zhongqiang Jia
- Key Laboratory of Integrated Pest Management on Crops in East China, Ministry of Agriculture, College of Plant Protection, Nanjing Agricultural University, Nanjing, 210095, PR China.
| | - Shenggan Wu
- State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-products, Institute of Quality and Standard for Agro-products, Zhejiang Academy of Agricultural Sciences, Hangzhou, 310021, PR China.
| | - Feifan Liu
- Key Laboratory of Integrated Pest Management on Crops in East China, Ministry of Agriculture, College of Plant Protection, Nanjing Agricultural University, Nanjing, 210095, PR China.
| | - Yingnan Wang
- Key Laboratory of Integrated Pest Management on Crops in East China, Ministry of Agriculture, College of Plant Protection, Nanjing Agricultural University, Nanjing, 210095, PR China.
| | - Genmiao Song
- Shangyu Nutrichem Co., Ltd, No.9 Weijiu Rd., Hangzhou Bay Shangyu Economic and Technological Development Area, Hangzhou, 312369, PR China.
| | - Xiaoli Chang
- Eco-Environmental Protection Research Institute, Shanghai Academy of Agricultural Sciences, Shanghai Engineering Research Centre of Low-carbon Agriculture, Shanghai, 201403, PR China.
| | - Chunqing Zhao
- Key Laboratory of Integrated Pest Management on Crops in East China, Ministry of Agriculture, College of Plant Protection, Nanjing Agricultural University, Nanjing, 210095, PR China.
| |
Collapse
|
10
|
Wang Q, Wang H, Zhang Y, Chen J, Upadhyay A, Bhowmick B, Hang J, Wu S, Liao C, Han Q. Functional analysis reveals ionotropic GABA receptor subunit RDL is a target site of ivermectin and fluralaner in the yellow fever mosquito, Aedes aegypti. PEST MANAGEMENT SCIENCE 2022; 78:4173-4182. [PMID: 35690922 DOI: 10.1002/ps.7035] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/12/2021] [Revised: 06/03/2022] [Accepted: 06/12/2022] [Indexed: 05/13/2023]
Abstract
BACKGROUND Ionotropic γ-aminobutyric acid (iGABA) receptors are involved in various physiological activities in insects, including sleep, olfactory memory, movement, and resistance to viruses. Ivermectin and fluralaner can disturb the insect nervous system by binding to iGABA receptors, and are therefore an effective means for controlling insect pests. However, the molecular mechanisms underlying the insecticidal effect of both the compounds on Aedes. aegypti remain unexplored. RESULTS In this study, we investigated the spatiotemporal expression profile of Ae. aegypti RDL (Ae-RDL), a subunit of iGABA receptor. RDL dsRNA suppressed the expression of Ae-RDL mRNA in Ae. aegypti larvae and adult by 60% and 50.67%, resepectly. However, the physiology of Ae. aegypti larvae was not significantly affected. The mortality of Ae. aegypti larvae and adult females subjected to Ae-RDL knockdown significantly decreased after exposure to ivermectin and fluralaner. Additionally, Ae-RDL was cloned into Xenopus laevis oocytes and characterized using the two-electrode voltage-clamp method. The inward current was induced by GABA binding to the functional Ae-RDL homomeric receptors at a median effective concentration (EC50 ) of 100.4 ± 59.95 μM (n > 3). The significant inhibitory effect of ivermectin and fluralaner on inward current indicated that both insecticides exerted a significant antagonistic effect on Ae-RDL. However, ivermectin also showed strong agonistic as well as weak activation effects on Ae-RDL. These contrasting effects of ivermectin on Ae-RDL depended on ivermectin concentration. CONCLUSION Our study revealed that Ae-RDL subunit is a target of ivermectin and fluralaner, providing new insights into the insecticidal mechanism of both compounds in Ae. aegypti. © 2022 Society of Chemical Industry.
Collapse
Affiliation(s)
- Qiuhui Wang
- Laboratory of Tropical Veterinary Medicine and Vector Biology, School of Life Sciences, Hainan University, Haikou, China
- One Health Institute, Hainan University, Haikou, China
| | - Haocheng Wang
- Laboratory of Tropical Veterinary Medicine and Vector Biology, School of Life Sciences, Hainan University, Haikou, China
- One Health Institute, Hainan University, Haikou, China
| | - Yingxin Zhang
- Laboratory of Tropical Veterinary Medicine and Vector Biology, School of Life Sciences, Hainan University, Haikou, China
| | - Jing Chen
- Laboratory of Tropical Veterinary Medicine and Vector Biology, School of Life Sciences, Hainan University, Haikou, China
- One Health Institute, Hainan University, Haikou, China
| | - Archana Upadhyay
- Laboratory of Tropical Veterinary Medicine and Vector Biology, School of Life Sciences, Hainan University, Haikou, China
- One Health Institute, Hainan University, Haikou, China
| | - Biswajit Bhowmick
- Laboratory of Tropical Veterinary Medicine and Vector Biology, School of Life Sciences, Hainan University, Haikou, China
- One Health Institute, Hainan University, Haikou, China
| | - Jiayu Hang
- Laboratory of Tropical Veterinary Medicine and Vector Biology, School of Life Sciences, Hainan University, Haikou, China
| | - Shaoying Wu
- College of Plant Protection, Key Laboratory of Green Prevention and Control of Tropical Plant Diseases and Pests of Ministry of Education, Hainan University, Haikou, China
| | - Chenghong Liao
- Laboratory of Tropical Veterinary Medicine and Vector Biology, School of Life Sciences, Hainan University, Haikou, China
- One Health Institute, Hainan University, Haikou, China
| | - Qian Han
- Laboratory of Tropical Veterinary Medicine and Vector Biology, School of Life Sciences, Hainan University, Haikou, China
- One Health Institute, Hainan University, Haikou, China
| |
Collapse
|
11
|
Gürtler RE, Laiño MA, Alvedro A, Enriquez GF, Macchiaverna NP, Gaspe MS, Cardinal MV. Treatment of dogs with fluralaner reduced pyrethroid-resistant Triatoma infestans abundance, Trypanosoma cruzi infection and human-triatomine contact in the Argentine Chaco. Parasit Vectors 2022; 15:257. [PMID: 35831874 PMCID: PMC9277862 DOI: 10.1186/s13071-022-05343-2] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2022] [Accepted: 05/23/2022] [Indexed: 11/16/2022] Open
Abstract
Background Triatomine elimination efforts and the interruption of domestic transmission of Trypanosoma cruzi are hampered by pyrethroid resistance. Fluralaner, a long-lasting ectoparasiticide administered to dogs, substantially reduced site infestation and abundance of pyrethroid-resistant Triatoma infestans Klug (Heteroptera: Reduviidae) in an ongoing 10-month trial in Castelli (Chaco Province, Argentina). We assessed the effects of fluralaner on vector infection with T. cruzi and blood meal sources stratified by ecotope and quantified its medium-term effects on site infestation and triatomine abundance. Methods We conducted a placebo-controlled, before-and-after efficacy trial of fluralaner in 28 infested sites over a 22-month period. All dogs received either an oral dose of fluralaner (treated group) or placebo (control group) at 0 month post-treatment [MPT]. Placebo-treated dogs were rescue-treated with fluralaner at 1 MPT, as were all eligible dogs at 7 MPT. Site-level infestation and abundance were periodically assessed by timed manual searches with a dislodging aerosol. Vector infection was mainly determined by kDNA-PCR and blood meal sources were determined by enzyme-linked immunosorbent assay. Results In fluralaner-treated households, site infestation dropped from 100% at 0 MPT to 18–19% over the period 6–22 MPT while mean abundance plummeted from 5.5 to 0.6 triatomines per unit effort. In control households, infestation dropped similarly post-treatment. The overall prevalence of T. cruzi infection steadily decreased from 13.8% at 0–1 MPT (baseline) to 6.4% and subsequently 2.3% thereafter, while in domiciles, kitchens and storerooms it dropped from 17.4% to 4.7% and subsequently 3.3% thereafter. Most infected triatomines occurred in domiciles and had fed on humans. Infected-bug abundance plummeted after fluralaner treatment and remained marginal or nil thereafter. The human blood index of triatomines collected in domiciles, kitchens and storerooms highly significantly fell from 42.9% at baseline to 5.3–9.1% over the period 6–10 MPT, increasing to 36.8% at 22 MPT. Dog blood meals occurred before fluralaner administration only. The cat blood index increased from 9.9% at baseline to 57.9–72.7% over the period 6–10 MPT and dropped to 5.3% at 22 MPT, whereas chicken blood meals rose from 39.6% to 63.2–88.6%. Conclusion Fluralaner severely impacted infestation- and transmission-related indices over nearly 2 years, causing evident effects at 1 MPT, and deserves larger efficacy trials. Graphical Abstract ![]()
Supplementary Information The online version contains supplementary material available at 10.1186/s13071-022-05343-2.
Collapse
Affiliation(s)
- Ricardo Esteban Gürtler
- Laboratory of Eco-Epidemiology, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria, Buenos Aires, Argentina. .,Instituto de Ecología, Genética y Evolución de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas, Ciudad Universitaria, Buenos Aires, Argentina.
| | - Mariano Alberto Laiño
- Laboratory of Eco-Epidemiology, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria, Buenos Aires, Argentina.,Instituto de Ecología, Genética y Evolución de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas, Ciudad Universitaria, Buenos Aires, Argentina
| | - Alejandra Alvedro
- Laboratory of Eco-Epidemiology, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria, Buenos Aires, Argentina.,Instituto de Ecología, Genética y Evolución de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas, Ciudad Universitaria, Buenos Aires, Argentina
| | - Gustavo Fabián Enriquez
- Laboratory of Eco-Epidemiology, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria, Buenos Aires, Argentina.,Instituto de Ecología, Genética y Evolución de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas, Ciudad Universitaria, Buenos Aires, Argentina
| | - Natalia Paula Macchiaverna
- Laboratory of Eco-Epidemiology, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria, Buenos Aires, Argentina.,Instituto de Ecología, Genética y Evolución de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas, Ciudad Universitaria, Buenos Aires, Argentina
| | - María Sol Gaspe
- Laboratory of Eco-Epidemiology, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria, Buenos Aires, Argentina.,Instituto de Ecología, Genética y Evolución de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas, Ciudad Universitaria, Buenos Aires, Argentina
| | - Marta Victoria Cardinal
- Laboratory of Eco-Epidemiology, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria, Buenos Aires, Argentina. .,Instituto de Ecología, Genética y Evolución de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas, Ciudad Universitaria, Buenos Aires, Argentina.
| |
Collapse
|
12
|
Lavan R, Normile D, Husain I, Singh A, Armstrong R, Heaney K. An assessment of canine ectoparasiticide administration compliance in the USA. Parasit Vectors 2022; 15:32. [PMID: 35062996 PMCID: PMC8780395 DOI: 10.1186/s13071-021-05134-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2021] [Accepted: 12/16/2021] [Indexed: 11/16/2022] Open
Abstract
Background This study evaluated the timing of dog owner ectoparasiticide purchases to estimate administration compliance and assess the consequent impact of dose purchase gaps on the proportion of time that dogs were protected over a 12-month period. Methods Ectoparasiticide purchase transactions over a 12-month period were evaluated for 626 US veterinary hospitals to determine dose purchase timing and identify consequent gaps between dose administration in dogs. Orally administered prescription ectoparasitic medications with active ingredients from the isoxazoline family (afoxolaner, fluralaner, lotilaner, or sarolaner) were included in the analysis. A period was calculated for each of the four isoxazoline-containing medications that represented the duration of protection provided by two doses of ectoparasiticide plus the average gap between these two doses. The maximum percentage of time possible for ectoparasiticide protection for this aggregate period was then calculated for each active ingredient. Results Ectoparasiticide transaction records of owners were analyzed for 506,637 dogs. These showed that 43% of dog owners purchased just one dose over the 12-month period considered. If a dog owner purchased more than one dose, then the timing of their transactions could create a time gap between the completion of ectoparasite protection from the first dose and onset of protection from the subsequent purchase and administration of the second dose. Such gaps were observed in purchases made by 31–65% of dog owners, depending on the selected active ingredient and number of doses. The average gap duration between dose purchases was calculated for all possible dose combinations over 12 months of ectoparasite protection. Time gaps between the first and second doses are as follows: for sarolaner, 20.3 weeks; for afoxolaner, 12.9 weeks; for fluralaner ,12.8 weeks; and for lotilaner, 8.9 weeks. The proportion of time when protection was provided during the aggregate period between administration of the first and second doses was as follows: for fluralaner, 65%; for lotilaner, 49%; for afoxolaner, 40%; and for sarolaner, 30%. Conclusions Dog owner ectoparasiticide purchase transactions showed that there were time gaps between doses leading to reduced ectoparasite protection. The longer re-administration interval for fluralaner, a consequence of its extended duration of activity, resulted in dog owners gaining the greatest proportion of ectoparasite protection time with this medication compared with shorter-acting monthly re-treatment medications. Graphical Abstract ![]()
Collapse
|
13
|
Huggins LG, Stevenson M, Baydoun Z, Mab R, Khouri Y, Schunack B, Traub RJ. Field trial investigating the efficacy of a long-acting imidacloprid 10%/flumethrin 4.5% polymer matrix collar (Seresto®, Elanco) compared to monthly topical fipronil for the chemoprevention of canine tick-borne pathogens in Cambodia. CURRENT RESEARCH IN PARASITOLOGY & VECTOR-BORNE DISEASES 2022; 2:100095. [PMID: 35865719 PMCID: PMC9294050 DOI: 10.1016/j.crpvbd.2022.100095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/11/2022] [Revised: 06/19/2022] [Accepted: 06/22/2022] [Indexed: 11/26/2022]
Abstract
The tropical brown dog tick, Rhipicephalus linnaei, commonly infests canines in the tropics and is an important vector for disease-causing and sometimes lethal pathogens including Babesia spp., Ehrlichia canis, Hepatozoon canis and Anaplasma platys. In tropical climates ticks and their pathogens exert an extremely high infection pressure on unprotected dogs. To protect canines in such regions, effective acaricidal products possessing a speed of kill that blocks pathogen transmission is paramount. We conducted a 12-month community trial to compare the chemoprophylactic efficacy of two topical commercial acaricidal formulations: an imidacloprid 10% and flumethrin 4.5%, 8-month acting collar (Seresto®) against a monthly spot-on containing 12% w/v fipronil (Detick, Thailand). In a separate analysis, we used baseline data collected at the start of the trial to quantify tick-borne pathogen (TBP) infection status in dogs with a prior history of being administered a systemically-acting (isoxazoline) versus a topically-acting ectoparasiticide. We found that both topical products in the community trial demonstrated high efficacy at protecting dogs from ticks and TBP, with Seresto® demonstrating a moderate increase in protection at 3 (95% confidence interval (CI): 1–5) TBP-positive dogs per 100 dog-years at risk compared to 11 (95% CI: 4–26) TBP-positive dogs per 100 dog-years at risk for those on fipronil. Additionally, at baseline dogs treated with commercial systemic isoxazoline acaricides prior to the trial’s commencement were 2.7 (95% CI: 0.5–15.0) times more likely to be TBP-positive compared to dogs that had been topically treated, highlighting such isoxazoline products as being less efficacious than topical products at preventing canine TBP acquisition in a tropical setting. Chemopreventive products against ectoparasite infestation are essential for dog health in the tropics. Prevalence of canine tick-borne pathogens was higher in dogs on systemic ectoparasiticides than those on topical ones. Seresto® demonstrated better protection against canine tick-borne pathogen infection than a fipronil formulation.
Collapse
|
14
|
Qu S, Zhu L, Wang Q, Wang X. Design, Synthesis and Insecticidal Activity of 3-Arylisoxazoline-N-alkylpyrazole-5-carboxamide Derivatives against Tetranychus urticae Koch. HETEROCYCLES 2022. [DOI: 10.3987/com-21-14593] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
|
15
|
Queiroga TBD, Gomez LCP, de Sena ER, Dos Santos WV, Ferreira HRP, de Araújo-Neto VT, Barbosa-Silva AN, Brito CRDN, Lima RKDR, Fagundes-Neto JC, Galvão LMDC, de Medeiros HR, da Câmara ACJ, Nascimento MSL, Gama RA, Guedes PMM. Insecticidal efficacy of fluralaner (Bravecto ®) against Triatoma brasiliensis, a major vector of Trypanosoma cruzi in Brazil. Parasit Vectors 2021; 14:456. [PMID: 34488865 PMCID: PMC8422713 DOI: 10.1186/s13071-021-04978-x] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2021] [Accepted: 08/24/2021] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Triatomines are responsible for the vector transmission of the protozoan parasite Trypanosoma cruzi, which causes Chagas disease. Triatoma brasiliensis is the main vector of the parasite in Brazil, and dogs are an important reservoir of the parasite. The aim of this study was to evaluate the insecticidal effect of fluralaner (Bravecto®) on T. brasiliensis after a blood meal in treated dogs. METHODS Healthy mongrel dogs (n = 8) were recruited from the Zoonoses Control Center (ZCC) in the city of Natal, Rio Grande do Norte, Brazil, and randomized into two groups, a fluralaner (Bravecto®)-treated group (n = 4) and a control group (n = 4). Colony-reared third-, fourth- and fifth-instar nymphs of T. brasiliensis nymphs (n = 10) were allowed to feed on dogs from both groups for 30-40 min, once monthly, for up to 12 months. Bug mortality was observed up to 5 days after each blood meal. RESULTS Mortality in triatomines which had a blood meal on fluralaner (Bravecto®)-treated dogs was 100% for up to 7 months after treatment, with mortality decreasing to 66.4% after 8 months, 57% after 9 months, 35% after 10 months, 10% after 11 months and 0% after 12 months. The mortality of triatomines that fed on non-treated control dogs was always ≤ 2.5%. CONCLUSIONS Our results suggest that fluralaner (Bravecto®) treatment of dogs induces long-term mortality of T. brasiliensis after the blood meal. This is a potential approach to be used to control vector transmission of T. cruzi, the etiological agent of Chagas disease, especially in endemic areas.
Collapse
Affiliation(s)
| | | | - Eduardo Rodrigues de Sena
- Graduate Program in Parasitary Biology, Federal University of Rio Grande Do Norte, Natal, Rio Grande Do Norte, Brazil
| | - Wilo Victor Dos Santos
- Graduate Program in Parasitary Biology, Federal University of Rio Grande Do Norte, Natal, Rio Grande Do Norte, Brazil
| | | | - Vicente Toscano de Araújo-Neto
- Graduate Program in Pharmaceutical Sciences, Federal University of Rio Grande Do Norte, Natal, Rio Grande Do Norte, Brazil
| | - Andressa Noronha Barbosa-Silva
- Graduate Program in Pharmaceutical Sciences, Federal University of Rio Grande Do Norte, Natal, Rio Grande Do Norte, Brazil
| | - Carlos Ramon do Nascimento Brito
- Department of Clinical and Toxicological Analyses, Federal University of Rio Grande Do Norte, Natal, Rio Grande Do Norte, Brazil
| | | | | | - Lúcia Maria da Cunha Galvão
- Department of Clinical and Toxicological Analyses, Federal University of Rio Grande Do Norte, Natal, Rio Grande Do Norte, Brazil
| | - Henrique Rocha de Medeiros
- Agricultural School of Jundiaí, Federal University of Rio Grande Do Norte, Macaíba, Rio Grande Do Norte, Brazil
| | - Antônia Cláudia Jácome da Câmara
- Department of Clinical and Toxicological Analyses, Federal University of Rio Grande Do Norte, Natal, Rio Grande Do Norte, Brazil
| | - Manuela Sales Lima Nascimento
- Department of Microbiology and Parasitology, Federal University of Rio Grande Do Norte, Natal, Rio Grande Do Norte, Brazil
| | - Renata Antonaci Gama
- Department of Microbiology and Parasitology, Federal University of Rio Grande Do Norte, Natal, Rio Grande Do Norte, Brazil
| | - Paulo Marcos Matta Guedes
- Department of Microbiology and Parasitology, Federal University of Rio Grande Do Norte, Natal, Rio Grande Do Norte, Brazil.
| |
Collapse
|
16
|
Forster S, Wiseman S, Snyder DE. Field study to investigate the effectiveness and safety of a novel orally administered combination drug product containing milbemycin oxime and lotilaner (Credelio ® Plus) against natural flea and tick infestations on dogs presented as veterinary patients in Europe. Parasit Vectors 2021; 14:299. [PMID: 34088338 PMCID: PMC8178840 DOI: 10.1186/s13071-021-04808-0] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2021] [Accepted: 05/25/2021] [Indexed: 11/11/2022] Open
Abstract
BACKGROUND A pivotal randomised, blinded, positive-controlled, multicentre, European field study was conducted to evaluate the effectiveness and safety of a novel combination tablet of lotilaner and milbemycin oxime (Credelio® Plus) administered orally to client-owned dogs naturally infested with fleas and/or ticks. METHODS In this field study, households with flea- or tick-infested dog(s) were enrolled on Day 0 into the study to provide data for either the tick or flea infestation cohorts. Households were randomised in a 2:1 ratio to receive either the combination investigational product (IP, Credelio Plus® tablets) or the control product (CP: Nexgard Spectra® tablets). Dogs were administered IP (flea cohort n = 135; tick cohort: n = 147) or CP (flea cohort: n = 67; tick cohort: n = 74) once every 4 weeks for a total of three times at a dose rate of 20.0-41.5 mg/kg bodyweight lotilaner and 0.75-1.53 mg/kg bodyweight milbemycin oxime (IP) or as recommended (CP). Percentage reduction was calculated by comparing individual dog flea and tick counts at each assessed post-treatment time point to their respective baseline (pre-treatment) infestation. Resolution of the clinical signs of flea allergy dermatitis (FAD) was assessed in flea-allergic dogs on the days that flea counts were performed. RESULTS Flea effectiveness of Credelio Plus® after 3 consecutive monthly treatments was 100% against Ctenocephalides felis, C. canis and Pulex irritans. Tick effectiveness of Credelio Plus® over the same time frame was 99.3% for Ixodes ricinus and 100% against Rhipicephalus sanguineus (s.l.). Flea effectiveness of the CP after three consecutive monthly treatments was 100% against C. felis, C. canis and P. irritans. Tick effectiveness of the CP over the same time frame was 99.8% for I. ricinus and 100% against R. sanguineus. Credelio Plus® was well tolerated based on the safety assessments in all treated dogs in this field study. Within both treatment groups there was a reduction in total FAD scores from baseline. CONCLUSIONS This pivotal European field study demonstrated the excellent effectiveness and safety of a combination of lotilaner and milbemycin oxime (Credelio Plus®) administered orally to dogs naturally infested with fleas and/or ticks.
Collapse
Affiliation(s)
- Sophie Forster
- Elanco Animal Health, Bartley Way, Bartley Wood Business Park, Hook, Hants, RG27 9XA, UK
| | - Scott Wiseman
- Elanco Animal Health, Bartley Way, Bartley Wood Business Park, Hook, Hants, RG27 9XA, UK
| | - Daniel E Snyder
- Daniel E. Snyder, DVM PhD. Consulting, LLC, Indianapolis, IN, 46229, USA.
| |
Collapse
|
17
|
Hinds LA, Grice D, Watson DM, Jacob J. Efficacy of a combined insecticide-rodenticide product on ectoparasite and commensal rodent mortality. PEST MANAGEMENT SCIENCE 2021; 77:1160-1168. [PMID: 33201557 DOI: 10.1002/ps.6179] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/16/2020] [Revised: 11/10/2020] [Accepted: 11/17/2020] [Indexed: 06/11/2023]
Abstract
BACKGROUND Ectoparasites may transfer zoonotic pathogens from rodents to humans or livestock when rodents are managed with rodenticides. This could be minimized using a product combining a rodenticide with a delayed action and a systemic insecticide/acaricide that rapidly kills ectoparasites. Such a combination was tested in commensal pest rodent species to assess efficacy and timing of responses in rodents, and fleas and ticks feeding on them. Ticks or fleas attached to rats (Rattus norvegicus) and house mice (Mus musculus domesticus) were exposed to a product containing brodifacoum (50 ppm) and fipronil (40 ppm) for three days. RESULTS 98-100% of fleas on treated rodents died within one to two days after first exposure, whereas >90% fleas survived on control rodents. The effect persisted for four or more days after bait uptake. Ticks started to succumb to the effect of the combination product within one day (mice) and within four days (rats) of first exposure, with all ticks dying by Day (D)8. Tick survival in control rodents was 90-100%. Rodent mortality began at D3 (rats) and D4 (mice) after first consumption of product and all were dead by D9 (rats) and D7 (mice). CONCLUSION This product effectively killed ectoparasites and rodents. Flea mortality was swift and complete, generally within one day of exposure, whereas it took ticks up to four days to die, but before the rats and house mice died. The combination product might help to prevent ectoparasites migrating from dying rodents to another host. Field trials are warranted. © 2020 Society of Chemical Industry.
Collapse
Affiliation(s)
- Lyn A Hinds
- CSIRO Health and Biosecurity, Canberra, Australia
| | - David Grice
- CSIRO Health and Biosecurity, Canberra, Australia
| | | | - Jens Jacob
- Federal Research Centre for Cultivated Plants, Julius Kühn Institute (JKI), Institute for Plant Protection in Horticulture and Forests, Vertebrate Research, Münster, Germany
| |
Collapse
|
18
|
Queiroga TBD, Ferreira HRP, Dos Santos WV, de Assis ABL, de Araújo Neto VT, da Câmara ACJ, Fagundes Neto JC, Dos Reis RK, Nascimento MSL, Gama RA, Guedes PMM. Fluralaner (Bravecto®) induces long-term mortality of Lutzomyia longipalpis after a blood meal in treated dogs. Parasit Vectors 2020; 13:609. [PMID: 33276818 PMCID: PMC7716428 DOI: 10.1186/s13071-020-04489-1] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2020] [Accepted: 11/19/2020] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Leishmania infantum is the etiological agent of visceral leishmaniasis (VL) in the New World, where the sand fly Lutzomyia longipalpis and domestic dogs are considered the main vector and host reservoirs, respectively. Systemic insecticides have been studied as an alternative to control vector-borne diseases, including VL. Fluralaner, an isoxazoline class compound, is a systemic insecticide used in dogs, with proven efficiency against different species of phlebotomine sand flies. However, to date no studies have demonstrated the efficacy of fluralaner on Lu. longipalpis. The aim of this study was to evaluate the insecticidal effect of fluralaner (Bravecto®) on the sand fly Lu. longipalpis after blood meal in treated dogs. METHODS Healthy mongrel dogs (n = 8) were recruited from the Zoonoses Control Center in the city of Natal, Rio Grande do Norte, Brazil, and randomized into two groups: fluralaner treated (n = 4) and non-treated control (n = 4). Colony-reared female specimens of Lu. longipalpis (n = 20) were allowed to feed on all dogs for 40 min before treatment (for fluralaner-treated dogs), at day 1 after treatment and then monthly until 1 year post-treatment. RESULTS In the treatment group, there was 100% mortality of Lu. longipalpis for up to 5 months after treatment initiation, decreasing to 72.5% at 6 months post-treatment initiation. The efficacy of fluralaner ranged from 100% at day 1 (P = 0.0002) to 68% ( P = 0.0015) at 6 months, decreasing to 1.4% at 1 year post-treatment. Sand fly mortality carried out blood meal in non-treated control dogs remained constant at ≤ 15%. CONCLUSIONS Taken together, our results suggest that fluralaner may be used as a control strategy for VL in dogs in VL endemic areas.
Collapse
Affiliation(s)
| | | | - Wilo Victor Dos Santos
- Graduate Program in Parasitary Biology, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil
| | - Ana Beatriz Lourenço de Assis
- Graduate Program in Parasitary Biology, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil
| | - Vicente Toscano de Araújo Neto
- Graduate Program in Pharmaceutical Sciences, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil
| | - Antônia Cláudia Jácome da Câmara
- Department of Clinical and Toxicological Analyses, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil
| | | | | | - Manuela Sales Lima Nascimento
- Department of Microbiology and Parasitology, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil
| | - Renata Antonaci Gama
- Department of Microbiology and Parasitology, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil
| | - Paulo Marcos Matta Guedes
- Department of Microbiology and Parasitology, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil.
| |
Collapse
|
19
|
Kumar G, Shankar R. 2-Isoxazolines: A Synthetic and Medicinal Overview. ChemMedChem 2020; 16:430-447. [PMID: 33029886 DOI: 10.1002/cmdc.202000575] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2020] [Revised: 09/26/2020] [Indexed: 02/03/2023]
Abstract
Isoxazolines are nitrogen- and oxygen-containing five-membered heterocyclic scaffolds with extensive biological activities. This framework can be readily obtained in good to excellent yields through 1,3-dipolar cycloaddition between nitrones with alkynes or allenes, aryl/alkyl halides, alkynes, and oxaziridines under mild conditions. This scaffold has been an emerging area of interest for many researchers given their wide range of bioactivities. Herein we review synthetic strategies toward isoxazolines and the role these efforts have had in enhancing the biological activity of natural products and synthetic compounds such as antitubercular agents, COX-1 inhibitors, COX-2 inhibitors (e. g., valdecoxib), nicotinic receptor modulators, and MIF inhibitors. With a focus on efforts from 2010 onward, this review provides in-depth coverage of the design and biological evaluation of isoxazoline systems and their impact on various pathologies.
Collapse
Affiliation(s)
- Gulshan Kumar
- Academy of Scientific and Innovative Research (AcSIR), CSIR-Indian Institute of Integrative Medicine, Jammu Campus, Jammu, 180001, India.,Bio-organic Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Jammu Campus, Jammu, 180001, India
| | - Ravi Shankar
- Academy of Scientific and Innovative Research (AcSIR), CSIR-Indian Institute of Integrative Medicine, Jammu Campus, Jammu, 180001, India.,Bio-organic Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Jammu Campus, Jammu, 180001, India
| |
Collapse
|
20
|
Neves RDCDSM, Barros LA, Mendes SMC, Amorim TIDSWDAD, Ferraz VP, Mateus LADF, Leite JDS, Ferreira AMR. The sensitivity of Demodex canis (Acari: Demodicidae) to the essential oil of Melaleuca alternifolia - an in vitro study. REVISTA BRASILEIRA DE PARASITOLOGIA VETERINARIA 2020; 29:e005220. [PMID: 32935769 DOI: 10.1590/s1984-29612020059] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/16/2020] [Accepted: 06/08/2020] [Indexed: 11/21/2022]
Abstract
The essential oil of the Melaleuca alternifolia (Maiden & Betche) (tea tree oil) has been effective in previous studies, in the treatment of infestation by Demodex mites in humans. The present study aimed at evaluating the in vitro acaricidal effect of this herbal medicine on Demodex canis. For the parasitological examination, samples were collected from a dog's skin and examined using optical microscopy. Only samples with intact mites and with evident movement of chelicerae and tarsi were selected. Twenty-one samples were tested with the oil, in seven different concentrations: 100%; 50%; 25%; 12.5%; 6.25%; 5.0% and 3.13%. Three samples were tested with the positive control amitraz, and three with the negative control neutral shampoo. The interval between the time the solution was added and the moment the movement of the last mite ceased defined the survival time in the sample. By comparing the times at different concentrations and controls, the results showed that the higher the concentration of the oil, the more quickly its lethal effect occurred, and that the survival times in the controls were longer than in the different concentrations of melaleuca oil.
Collapse
Affiliation(s)
- Rita de Cássia da Silva Machado Neves
- Área de Concentração em Clínica e Reprodução Animal, Programa de Pós-graduação em Medicina Veterinária, Faculdade de Veterinária, Universidade Federal Fluminense - UFF, Niterói, RJ, Brasil.,Hospital Veterinário Professor Firmino Marsico Filho, Faculdade de Veterinária, Universidade Federal Fluminense - UFF, Niterói, RJ, Brasil
| | - Luciano Antunes Barros
- Área de Concentração em Clínica e Reprodução Animal, Programa de Pós-graduação em Medicina Veterinária, Faculdade de Veterinária, Universidade Federal Fluminense - UFF, Niterói, RJ, Brasil.,Departamento de Saúde Coletiva e Saúde Pública Veterinária, Faculdade de Veterinária, Universidade Federal Fluminense - UFF, Niterói, RJ, Brasil
| | - Shihane Mohamad Costa Mendes
- Departamento de Saúde Coletiva e Saúde Pública Veterinária, Faculdade de Veterinária, Universidade Federal Fluminense - UFF, Niterói, RJ, Brasil
| | | | - Vany Perpétua Ferraz
- Departamento de Química, Instituto de Ciências Exatas, Universidade Federal de Minas Gerais - UFMG, Belo Horizonte, MG, Brasil
| | | | - Juliana da Silva Leite
- Área de Concentração em Clínica e Reprodução Animal, Programa de Pós-graduação em Medicina Veterinária, Faculdade de Veterinária, Universidade Federal Fluminense - UFF, Niterói, RJ, Brasil.,Hospital Veterinário Professor Firmino Marsico Filho, Faculdade de Veterinária, Universidade Federal Fluminense - UFF, Niterói, RJ, Brasil.,Departamento de Patologia e Clínica Veterinária, Faculdade de Veterinária, Universidade Federal Fluminense - UFF, Niterói, RJ, Brasil
| | - Ana Maria Reis Ferreira
- Área de Concentração em Clínica e Reprodução Animal, Programa de Pós-graduação em Medicina Veterinária, Faculdade de Veterinária, Universidade Federal Fluminense - UFF, Niterói, RJ, Brasil.,Hospital Veterinário Professor Firmino Marsico Filho, Faculdade de Veterinária, Universidade Federal Fluminense - UFF, Niterói, RJ, Brasil.,Departamento de Patologia e Clínica Veterinária, Faculdade de Veterinária, Universidade Federal Fluminense - UFF, Niterói, RJ, Brasil
| |
Collapse
|
21
|
Mueller RS, Rosenkrantz W, Bensignor E, Karaś-Tęcza J, Paterson T, Shipstone MA. Diagnosis and treatment of demodicosis in dogs and cats: Clinical consensus guidelines of the World Association for Veterinary Dermatology. Vet Dermatol 2020; 31:5-27. [PMID: 31957202 DOI: 10.1111/vde.12806] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/12/2019] [Indexed: 12/01/2022]
Abstract
BACKGROUND Demodicosis is a common disease in small animal veterinary practice worldwide with a variety of diagnostic and therapeutic options. OBJECTIVES To provide consensus recommendations on the diagnosis, prevention and treatment of demodicosis in dogs and cats. METHODS AND MATERIALS The authors served as a Guideline Panel (GP) and reviewed the literature available before December 2018. The GP prepared a detailed literature review and made recommendations on selected topics. A draft of the document was presented at the North American Veterinary Dermatology Forum in Maui, HI, USA (May 2018) and at the European Veterinary Dermatology Congress in Dubrovnik, Croatia (September 2018) and was made available via the World Wide Web to the member organizations of the World Association for Veterinary Dermatology for a period of three months. Comments were solicited and responses were incorporated into the final document. CONCLUSIONS In young dogs with generalized demodicosis, genetic and immunological factors seem to play a role in the pathogenesis and affected dogs should not be bred. In old dogs and cats, underlying immunosuppressive conditions contributing to demodicosis should be explored. Deep skin scrapings are the diagnostic gold standard for demodicosis, but trichograms and tape squeeze preparations may also be useful under certain circumstances. Amitraz, macrocyclic lactones and more recently isoxazolines have all demonstrated good efficacy in the treatment of canine demodicosis. Therapeutic selection should be guided by local drug legislation, drug availability and individual case parameters. Evidence for successful treatment of feline demodicosis is strongest for lime sulfur dips and amitraz baths.
Collapse
Affiliation(s)
- Ralf S Mueller
- Centre for Clinical Veterinary Medicine, LMU Munich, Veterinaerstraße 13, 80539, Munich, Germany
| | | | - Emmanuel Bensignor
- Dermatology Referral Service, 75003, Paris, 35510 Cesson-Sévigné, and 44000, Nantes, France
| | - Joanna Karaś-Tęcza
- Dermawet Dermatology Service for Dogs and Cats, Odyńca 37 lok.1/2, 02-606, Warszawa, Poland
| | - Tara Paterson
- Small Animal Medicine & Surgery Department, School of Veterinary Medicine, St. George's University, PO Box #7, St George's, Grenada, West Indies
| | - Michael A Shipstone
- Dermatology for Animals, 263 Appleby Road, Stafford Heights, Brisbane, Queensland, 4053, Australia
| |
Collapse
|
22
|
Allen K, Little S, Petersen M, Gruntmeir J, Barrett A, Herrin B, Starkey L, Sun F, Guerino F. Evaluation of oral fluralaner (Bravecto ®) for efficacy against nymphs of Amblyomma americanum and Rhipicephalus sanguineus (sensu lato). Parasit Vectors 2020; 13:315. [PMID: 32552774 PMCID: PMC7302130 DOI: 10.1186/s13071-020-04179-y] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2020] [Accepted: 06/08/2020] [Indexed: 02/08/2023] Open
Abstract
BACKGROUND Amblyomma americanum and Rhipicephalus sanguineus (sensu lato) nymphs commonly feed on and transmit pathogens to dogs (Canis familiaris). Control of immature and adult tick life stages is necessary to fully protect animals. We evaluated efficacy of oral fluralaner (Bravecto®) against induced infestations with A. americanum and R. sanguineus (s.l.) nymphs on dogs in two experiments. METHODS In each experiment, 10 dogs were administered oral fluralaner chewable tablets one time on Day 0 at a targeted minimum dose of 25 mg/kg body weight and 10 dogs remained non-treated controls. Dogs were infested with two groups of 50 A. americanum nymphs and two groups of 50 R. sanguineus (s.l.) nymphs on Days -1, 6, 28, 56 and 84. At 48 h and 72 h post-infestation, nymphs were collected from dogs, assessed as live or dead, and enumerated into categories defining attachment and engorgement status. Fluralaner efficacy was determined in separate analyses against all live nymphs and against live-fed nymphs, i.e. live nymphs that were attached to dogs at the time of collection and/or were engorged. Fluralaner was considered effective when mean numbers of live ticks were reduced in fluralaner-treated dogs by ≥ 90%. RESULTS Fluralaner efficacy against all live and live-fed A. americanum nymphs in the first experiment was > 94% on all collection days. Efficacy against all live R. sanguineus (s.l.) nymphs in the first experiment was > 96% on all collection days excluding the 48 h counts for infestations on Days 28 (83.7%), 56 (82.9%) and 84 (86.7%); efficacy against live-fed R. sanguineus (s.l.) nymphs was > 95% on all 48 h/72 h count days. Fluralaner efficacy against all live A. americanum nymphs in the second experiment was > 93% on all collection days for 8 weeks excluding the 48 h count for infestation on Day 56 (87.8%); efficacy against live-fed A. americanum nymphs was > 91% on all count days for 8 weeks. Efficacy against all live R. sanguineus (s.l.) nymphs in the second experiment was > 91% on all 72 h collection days except for infestations on Days 28 (76.8%) and 56 (86.3%); efficacy against live-fed R. sanguineus (s.l.) nymphs was 100% on all 72 h count days. CONCLUSIONS A single administration of oral fluralaner to dogs is effective against A. americanum and R. sanguineus (s.l.) nymphs for up to 12 weeks.
Collapse
Affiliation(s)
- Kelly Allen
- Department of Veterinary Pathobiology, Oklahoma State University, College of Veterinary Medicine, Stillwater, Oklahoma 74078 USA
| | - Susan Little
- Department of Veterinary Pathobiology, Oklahoma State University, College of Veterinary Medicine, Stillwater, Oklahoma 74078 USA
| | | | - Jeff Gruntmeir
- Department of Comparative Diagnostics and Population Medicine, University of Florida, College of Veterinary Medicine, Gainesville, Florida 32611 USA
| | - Anne Barrett
- Merck Animal Health, Madison, New Jersey 07940 USA
| | - Brian Herrin
- Diagnostic Medicine/Pathobiology, Kansas State University, College of Veterinary Medicine, Manhattan, Kansas 66506 USA
| | - Lindsay Starkey
- Department of Pathobiology, Auburn University, College of Veterinary Medicine, Auburn, Alabama 36849 USA
| | - Fangshi Sun
- Merck Animal Health, Madison, New Jersey 07940 USA
| | | |
Collapse
|
23
|
Efficacy of a novel oral chewable tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) against natural flea and tick infestations on dogs presented as veterinary patients in Europe. Parasit Vectors 2020; 13:72. [PMID: 32113486 PMCID: PMC7049391 DOI: 10.1186/s13071-020-3946-1] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2019] [Accepted: 02/04/2020] [Indexed: 11/26/2022] Open
Abstract
Background A novel chewable oral tablet containing sarolaner, moxidectin and pyrantel (Simparica Trio™) has recently been developed to provide persistent protection against flea and tick infections for a month, treatment of hookworm and roundworm infections and prevention of heartworm and lungworm disease in dogs. Two field studies were conducted to evaluate the safety and efficacy of Simparica Trio™ against natural flea and tick infestations on dogs in Europe. Methods Dogs with natural flea or tick infestations were allocated randomly to treatment on Day 0 with either Simparica Trio™ tablets (flea study: n = 297; tick study: n = 189) to provide 1.2–2.4 mg/kg sarolaner, 24–48 µg/kg moxidectin and 5–10 mg/kg pyrantel (as pamoate salt) or with NexGard® Spectra (afoxolaner + milbemycin oxime) according to the label instructions (flea study: n = 164; tick study: n = 91). Efficacy was calculated based on the mean percent reduction in live parasite counts compared to the respective pre-treatment counts on Days 14 and 30 in the flea study and on Days 7, 14, 21 and 30 in the tick study. To count the fleas, the dog’s entire coat was systematically combed using an extra fine-tooth flea comb until all fleas were removed. For the tick counts, the dog’s entire coat was searched manually. Resolution of the clinical signs of flea allergy dermatitis (FAD) was assessed in flea allergic dogs in the flea study. Palatability was assessed in both studies. Results Simparica Trio™ was well tolerated in both studies. Efficacy against fleas was ≥ 97.9% in the Simparica Trio™ group and ≥ 96.1% in the NexGard® Spectra group. Efficacy against ticks was ≥ 94.8% in the Simparica Trio™ group and ≥ 94.4% in the NexGard® Spectra group. Clinical signs of flea allergy dermatitis improved following treatment with Simparica Trio™. Simparica Trio™ tablets were voluntarily and fully consumed on ≥ 78% of the 485 occasions they were offered. Conclusions A single oral dose of Simparica Trio™ was safe and highly efficacious against naturally occurring flea and tick infestations for 1 month on dogs. Clinical signs of FAD improved following treatment. Simparica Trio™ was voluntarily and readily consumed by most dogs.
Collapse
|
24
|
Pelletier J, Rocheleau JP, Aenishaenslin C, Beaudry F, Dimitri Masson G, Lindsay LR, Ogden NH, Bouchard C, Leighton PA. Evaluation of fluralaner as an oral acaricide to reduce tick infestation in a wild rodent reservoir of Lyme disease. Parasit Vectors 2020; 13:73. [PMID: 32054498 PMCID: PMC7020370 DOI: 10.1186/s13071-020-3932-7] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2019] [Accepted: 02/03/2020] [Indexed: 01/19/2023] Open
Abstract
Background Lyme disease (LD) is an increasing public health threat in temperate zones of the northern hemisphere, yet relatively few methods exist for reducing LD risk in endemic areas. Disrupting the LD transmission cycle in nature is a promising avenue for risk reduction. This experimental study evaluated the efficacy of fluralaner, a recent oral acaricide with a long duration of effect in dogs, for killing Ixodes scapularis ticks in Peromyscus maniculatus mice, a known wildlife reservoir for Borrelia burgdorferi in nature. Methods We assigned 87 mice to 3 fluralaner treatment groups (50 mg/kg, 12.5 mg/kg and untreated control) administered as a single oral treatment. Mice were then infested with 20 Ixodes scapularis larvae at 2, 28 and 45 days post-treatment and we measured efficacy as the proportion of infesting larvae that died within 48 h. At each infestation, blood from 3 mice in each treatment group was tested to obtain fluralaner plasma concentrations (Cp). Results Treatment with 50 mg/kg and 12.5 mg/kg fluralaner killed 97% and 94% of infesting larvae 2 days post-treatment, but no significant effect of treatment on feeding larvae was observed 28 and 45 days post-treatment. Mouse Cp did not differ significantly between the two tested doses. Mean Cp decreased from 13,000 ng/ml in the 50 mg/kg group and 4000 ng/ml in the 12.5 mg/kg group at Day 2 to < 100 ng/ml in both groups at Day 45. Conclusions We provide the first evidence that fluralaner is effective for killing immature ticks in Peromyscus mice, a first step in evaluating its potential for treating wild rodents as a public health intervention to reduce LD risk in endemic areas.![]()
Collapse
Affiliation(s)
- Jérôme Pelletier
- Département de pathologie et microbiologie, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, QC, Canada. .,Groupe de recherche en épidémiologie des zoonoses et santé publique, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, QC, Canada. .,Centre de recherche en Santé Publique, Université de Montréal, Montréal, QC, Canada.
| | - Jean-Philippe Rocheleau
- Groupe de recherche en épidémiologie des zoonoses et santé publique, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, QC, Canada.,Département de santé animale, CÉGEP de Saint-Hyacinthe, Saint-Hyacinthe, QC, Canada
| | - Cécile Aenishaenslin
- Département de pathologie et microbiologie, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, QC, Canada.,Groupe de recherche en épidémiologie des zoonoses et santé publique, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, QC, Canada.,Centre de recherche en Santé Publique, Université de Montréal, Montréal, QC, Canada
| | - Francis Beaudry
- Groupe de recherche en pharmacologie animale, Département de biomédecine vétérinaire, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, QC, Canada
| | - Gabrielle Dimitri Masson
- Département de pathologie et microbiologie, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, QC, Canada.,Groupe de recherche en épidémiologie des zoonoses et santé publique, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, QC, Canada
| | - L Robbin Lindsay
- Zoonotic Diseases and Special Pathogens Division, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada
| | - Nicholas H Ogden
- Groupe de recherche en épidémiologie des zoonoses et santé publique, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, QC, Canada.,Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada, Saint-Hyacinthe, QC, Canada
| | - Catherine Bouchard
- Groupe de recherche en épidémiologie des zoonoses et santé publique, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, QC, Canada.,Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada, Saint-Hyacinthe, QC, Canada
| | - Patrick A Leighton
- Département de pathologie et microbiologie, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, QC, Canada.,Groupe de recherche en épidémiologie des zoonoses et santé publique, Faculté de médecine vétérinaire, Université de Montréal, Saint-Hyacinthe, QC, Canada.,Centre de recherche en Santé Publique, Université de Montréal, Montréal, QC, Canada
| |
Collapse
|
25
|
The brown dog tick Rhipicephalus sanguineus sensu Roberts, 1965 across Australia: Morphological and molecular identification of R. sanguineus s.l. tropical lineage. Ticks Tick Borne Dis 2019; 11:101305. [PMID: 31594688 DOI: 10.1016/j.ttbdis.2019.101305] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/24/2019] [Revised: 08/13/2019] [Accepted: 09/21/2019] [Indexed: 12/14/2022]
Abstract
The brown dog tick Rhipicephalus sanguineus (Latreille, 1806) is the most widely distributed tick species globally. Throughout the world there are at least two divergent lineages on dogs that are traditionally grouped into what was known as R. sanguineus. The species R. sanguineus was recently redescribed using a neotype reported from countries with a temperate climate. The second lineage distributed in countries with primarily tropical climates is currently designated R. sanguineus s.l. tropical lineage. Here, we present a comprehensive genetic evaluation of Australian brown dog ticks from across the continent that complements the morphological study of R. sanguineus sensu Roberts (1965). A total of 294 ticks were collected from dogs around Australia - including New South Wales, Queensland, the Northern Territory and Western Australia - for morphological identification. All ticks were morphologically identified as R. sanguineus sensu Roberts (1965). DNA was isolated from a single leg from morphologically characterised individuals from New South Wales (n = 14), Queensland (n = 18), Northern Territory (n = 7) and Western Australia (n = 13), together with ticks from Fiji (n = 1) and the Seychelles (n = 1) for comparison with Australian ticks. The study revealed three cox1 haplotypes clustered only with R. sanguineus s.l. tropical lineage'. An updated distribution of R. sanguineus sensu Roberts (1965) is compared to the 1965 distribution. In the Australian context, R. sanguineus s.l. has appeared in north-western New South Wales but remains absent from coastal New South Wales. Despite both temperate and tropical climates being present in Australia, only R. sanguineus s.l. tropical lineage was found. The evidence does not support the presence of the strictly defined brown dog tick, R. sanguineus by Nava et al. (2018) in Australia, because the examined ticks are genetically and morphologically distinct. We recommend using the term brown dog tick, R. sanguineus sensu Roberts (1965) for specimens from Australia.
Collapse
|
26
|
Gaens D, Rummel C, Schmidt M, Hamann M, Geyer J. Suspected neurological toxicity after oral application of fluralaner (Bravecto®) in a Kooikerhondje dog. BMC Vet Res 2019; 15:283. [PMID: 31391054 PMCID: PMC6686215 DOI: 10.1186/s12917-019-2016-4] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2019] [Accepted: 07/18/2019] [Indexed: 11/10/2022] Open
Abstract
Background Although the new isoxazoline drug fluralaner (Bravecto®) is generally well tolerated in dogs, adverse drug reactions involving neurological dysfunction occurred in individual dogs. However, most of these cases are documented inadequately and none of them is reported and discussed in the literature. As isoxazoline drugs target neuronal chloride channels with a clear preference for invertebrates, they are considered to have a good safety profile. However, pharmacodynamic effects in the nervous system of vertebrates cannot be ruled out completely. Case presentation A seven-month-old female Kooikerhondje dog was treated with Bravecto® at the recommended dose. About 24 h after administration, the dog exhibited signs of neurological toxicity, including generalized ataxia, myoclonic jerks, tremor of head and body, muscle twitching and oral dysphagia. All symptoms were transient and the dog fully recovered without any treatment after 10 h. Conclusion This case report describes transient occurrence of neurological dysfunction after administration of Bravecto®. It may help to better classify adverse drug reactions after application of isoxazoline drugs and documents a good prognosis even after occurrence of severe neurological dysfunction in the present case. Electronic supplementary material The online version of this article (10.1186/s12917-019-2016-4) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Daniela Gaens
- Institute of Pharmacology and Toxicology, Biomedical Research Center Seltersberg, Justus Liebig University Giessen, Schubertstr. 81, 35392, Giessen, Germany
| | - Christoph Rummel
- Institute of Veterinary Physiology and Biochemistry, Justus Liebig University Giessen, Giessen, Germany
| | - Martin Schmidt
- Department of Veterinary Clinical Sciences, Clinic for Small Animal-Surgery, Faculty of Veterinary Medicine, Justus-Liebig-University Giessen, Giessen, Germany
| | - Melanie Hamann
- Institute of Pharmacology and Toxicology, Biomedical Research Center Seltersberg, Justus Liebig University Giessen, Schubertstr. 81, 35392, Giessen, Germany
| | - Joachim Geyer
- Institute of Pharmacology and Toxicology, Biomedical Research Center Seltersberg, Justus Liebig University Giessen, Schubertstr. 81, 35392, Giessen, Germany.
| |
Collapse
|
27
|
Fisara P, Guerino F, Sun F. Efficacy of a spot-on combination of fluralaner plus moxidectin (Bravecto ® Plus) in cats following repeated experimental challenge with a field isolate of Ctenocephalides felis. Parasit Vectors 2019; 12:259. [PMID: 31122282 PMCID: PMC6533700 DOI: 10.1186/s13071-019-3512-x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/17/2019] [Accepted: 05/17/2019] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND A spot-on formulation of fluralaner plus moxidectin has been designed to provide long-term protection against fleas and ticks, prevent heartworm disease and treat gastrointestinal nematode infections in cats. The objective of this study was to determine the efficacy of this product against fleas collected from a household with repeated fipronil failures following owner-administered treatments. METHODS Thirty cats were randomized to three equal groups: (A) untreated controls; (B) to receive a single application of fluralaner plus moxidectin (Bravecto® Plus) at 40 mg/kg and 2 mg/kg body weight, respectively; and (C) three applications at one month intervals with a spot-on formulation of fipronil and (S)-methoprene (Frontline® Plus) at 0.5 ml manufacturer recommended dose. Flea challenges were completed on Days -6 (for randomization), -1, 7, 14, 28, 42, 56, 70, 77, 84 and 91. Flea counts were completed 48 hours after initial treatment and 48 hours following each subsequent challenge. RESULTS Fleas were found on all control and all fipronil and (S)-methoprene treated cats at every assessment. From Day 2 to Day 93, all cats in the fluralaner plus moxidectin group were flea-free, with one exception (Day 58; three fleas counted on one cat); control group flea counts ranged between 34-109, and fipronil and (S)-methoprene group counts ranged between 1-79. At each assessment after Day 0, compared to the control group, geometric mean flea counts were significantly lower in the fipronil and (S)-methoprene group (P ≤ 0.04) and in the fluralaner plus moxidectin group (P < 0.001), and mean flea counts in the fluralaner plus moxidectin group were significantly lower than those of the fipronil and (S)-methoprene group (P < 0.001). The efficacy of fluralaner plus moxidectin, based on geometric means, was 100% at each assessment post-Day 0 except on Day 58 when efficacy was 99.7%. In the fipronil and (S)-methoprene group efficacy ranged between 30.6-65.6%. CONCLUSIONS These findings demonstrate complete efficacy of fluralaner plus moxidectin against a flea isolate that was not controlled by fipronil and (S)-methoprene. This study provides confirmation of the consistent, sustained efficacy of topically applied fluralaner in the treatment and control of flea infestations in cats.
Collapse
Affiliation(s)
- Petr Fisara
- MSD Animal Health Australia Ltd., 26 Artisan Road, Seven Hills, NSW 2147 Australia
| | - Frank Guerino
- Merck Animal Health, 2 Giralda Farms, Madison, NJ 07940 USA
| | - Fangshi Sun
- Merck Animal Health, 2 Giralda Farms, Madison, NJ 07940 USA
| |
Collapse
|
28
|
Kluever BM, Iles DT, Gese EM. Ectoparasite burden influences the denning behavior of a small desert carnivore. Ecosphere 2019. [DOI: 10.1002/ecs2.2749] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022] Open
Affiliation(s)
- Bryan M. Kluever
- United States Department of Agriculture, Wildlife Services National Wildlife Research Center Florida Field Station Gainesville Florida 32641‐6033 USA
| | - David T. Iles
- Woods Hole Oceanographic Institution Woods Hole Massachusetts 02543 USA
| | - Eric M. Gese
- Department of Wildland Resources United States Department of Agriculture, Wildlife Services National Wildlife Research Center Utah State University Logan Utah 84322‐5230 USA
| |
Collapse
|
29
|
Junquera P, Hosking B, Gameiro M, Macdonald A. Benzoylphenyl ureas as veterinary antiparasitics. An overview and outlook with emphasis on efficacy, usage and resistance. Parasite 2019; 26:26. [PMID: 31041897 PMCID: PMC6492539 DOI: 10.1051/parasite/2019026] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2019] [Accepted: 04/11/2019] [Indexed: 01/17/2023] Open
Abstract
Six benzoylphenyl ureas are currently used in formulations approved as veterinary medicines: diflubenzuron for fly control mainly on cattle, lice and blowfly strike control on sheep, and lice control on farmed salmonids; lufenuron for flea control on dogs and cats and for lice control on farmed salmonids; triflumuron for lice and blowfly strike control on sheep; fluazuron for tick control on cattle; teflubenzuron for lice control on farmed salmon; and novaluron for fly and tick control on cattle and for flea control on dogs. Resistance to diflubenzuron and triflumuron has already been reported for sheep body lice and blowflies, and to fluazuron in cattle ticks. These and other minor veterinary usages, as well as the current status of resistance, are reviewed and perspectives for future opportunities are discussed based on unexplored potentials and threats posed by future resistance development.
Collapse
Affiliation(s)
| | - Barry Hosking
-
Elanco Australasia Pty. Limited Kemps Creek 2178
NSW Australia
| | - Marta Gameiro
-
Elanco Canada Limited 150 Research Lane, Suite 120 Guelph ON
N1G 4T2 Canada
| | - Alicia Macdonald
-
Elanco Canada Limited 150 Research Lane, Suite 120 Guelph ON
N1G 4T2 Canada
| |
Collapse
|
30
|
Laiño MA, Cardinal MV, Enriquez GF, Alvedro A, Gaspe MS, Gürtler RE. An oral dose of Fluralaner administered to dogs kills pyrethroid-resistant and susceptible Chagas disease vectors for at least four months. Vet Parasitol 2019; 268:98-104. [PMID: 30981313 DOI: 10.1016/j.vetpar.2019.03.005] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2019] [Revised: 03/15/2019] [Accepted: 03/16/2019] [Indexed: 11/24/2022]
Abstract
New vector control tools that can fit into a broader integrated vector management strategy are notably lacking. We conducted a seven-month randomized trial to assess the efficacy of a single oral dose of Fluralaner (Bravecto®) administered to dogs on the blood-feeding success, engorgement levels and mortality of pyrethroid-resistant and -susceptible Triatoma infestans third- and fifth-instar nymphs. The trial included 10 Fluralaner-treated and 10 placebo-treated (control) outbred healthy dogs residing in rural houses of the Argentine Chaco. Most (92.7%) of the 3017 triatomines exposed were able to blood-feed. Generalized linear models showed that blood-feeding success was not significantly modified by Fluralaner treatment, time posttreatment and their interaction. However, pyrethroid-susceptible fifth instars blood-fed significantly more frequently than susceptible third instars, and no significant differences were observed between the latter and resistant fifth instars. Engorgement levels were not significantly modified by Fluralaner treatment, time posttreatment and their interaction. Nearly all the triatomines that blood-fed on treated dogs up to 60 days posttreatment (DPT) died within 24 h regardless of pyrethroid susceptibility status combined with bug stage. Cumulative bug mortality over 4 days postexposure remained high over 90-120 DPT (70-81% in susceptible third and fifth instars, and 47-49% in resistant fifth instars), and was virtually nil at 210 DPT. Triatomines that fed on control dogs suffered marginal mortality (0-4%) except at 4 and 30 DPT. Fluralaner and xenointoxication are eligible for Phase III efficacy trials alone or combined with other methods in the frame of an integrated vector management strategy in areas with or without pyrethroid resistance.
Collapse
Affiliation(s)
- M A Laiño
- Universidad de Buenos Aires, Facultad de Ciencias Exactas y Naturales, Laboratory of Eco-Epidemiology, Ciudad Universitaria, C1428EHA, Buenos Aires, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas-Universidad de Buenos Aires, Instituto de Ecología, Genética y Evolución de Buenos Aires (IEGEBA), Ciudad Universitaria, C1428EHA, Buenos Aires, Argentina
| | - M V Cardinal
- Universidad de Buenos Aires, Facultad de Ciencias Exactas y Naturales, Laboratory of Eco-Epidemiology, Ciudad Universitaria, C1428EHA, Buenos Aires, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas-Universidad de Buenos Aires, Instituto de Ecología, Genética y Evolución de Buenos Aires (IEGEBA), Ciudad Universitaria, C1428EHA, Buenos Aires, Argentina.
| | - G F Enriquez
- Universidad de Buenos Aires, Facultad de Ciencias Exactas y Naturales, Laboratory of Eco-Epidemiology, Ciudad Universitaria, C1428EHA, Buenos Aires, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas-Universidad de Buenos Aires, Instituto de Ecología, Genética y Evolución de Buenos Aires (IEGEBA), Ciudad Universitaria, C1428EHA, Buenos Aires, Argentina
| | - A Alvedro
- Universidad de Buenos Aires, Facultad de Ciencias Exactas y Naturales, Laboratory of Eco-Epidemiology, Ciudad Universitaria, C1428EHA, Buenos Aires, Argentina
| | - M S Gaspe
- Universidad de Buenos Aires, Facultad de Ciencias Exactas y Naturales, Laboratory of Eco-Epidemiology, Ciudad Universitaria, C1428EHA, Buenos Aires, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas-Universidad de Buenos Aires, Instituto de Ecología, Genética y Evolución de Buenos Aires (IEGEBA), Ciudad Universitaria, C1428EHA, Buenos Aires, Argentina
| | - R E Gürtler
- Universidad de Buenos Aires, Facultad de Ciencias Exactas y Naturales, Laboratory of Eco-Epidemiology, Ciudad Universitaria, C1428EHA, Buenos Aires, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas-Universidad de Buenos Aires, Instituto de Ecología, Genética y Evolución de Buenos Aires (IEGEBA), Ciudad Universitaria, C1428EHA, Buenos Aires, Argentina
| |
Collapse
|
31
|
Rohdich N, Zschiesche E, Wolf O, Loehlein W, Pobel T, Gil MJ, Roepke RKA. Field effectiveness and safety of fluralaner plus moxidectin (Bravecto® Plus) against ticks and fleas: a European randomized, blinded, multicenter field study in naturally-infested client-owned cats. Parasit Vectors 2018; 11:598. [PMID: 30454052 PMCID: PMC6240940 DOI: 10.1186/s13071-018-3175-z] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/27/2018] [Accepted: 10/28/2018] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND A spot-on formulation containing fluralaner (280 mg/ml) plus moxidectin (14 mg/ml) (Bravecto® Plus) has been developed to provide broad spectrum parasite protection for cats. The effectiveness and safety of this product against ticks and fleas was assessed in a randomized, controlled, 12-week study in client-owned cats in Germany and Spain. METHODS Eligible households containing at least one cat with at least two fleas and/or two ticks were allocated randomly in a 2:1 ratio to a single treatment with fluralaner plus moxidectin on Day 0, or three 4-weekly treatments with fipronil (Frontline®). Veterinary staff, masked to treatment, completed tick and flea counts on each cat at 14 ± 2 (2 weeks), 28 ± 2 (4 weeks), 56 ± 2 (8 weeks) and 84 ± 2 days (12 weeks) after the initial treatment. RESULTS In total, 707 cats (257 with ticks) from 332 households (236 with fleas) were included. Ixodes ricinus (78%) and Rhipicephalus sanguineus complex (18%) ticks were the most commonly identified. Tick and flea counts were lower in the fluralaner plus moxidectin group than in the fipronil group throughout the study and the efficacy of fluralaner plus moxidectin exceeded 97 and 98%, respectively. At 12 weeks, 94.1 and 93.3% of cats from the fluralaner plus moxidectin and 92.2 and 60.3% of cats from the fipronil group were free of ticks and fleas, respectively. Fluralaner plus moxidectin was non-inferior to fipronil (P < 0.0001) at all assessments and superior to fipronil at 2 and 8 weeks for the proportion of cats free of ticks (P < 0.0001). Fluralaner plus moxidectin was superior to fipronil for the proportion of both households and cats free of fleas (P < 0.0001). Both products were safe and well tolerated. CONCLUSIONS A single application of fluralaner plus moxidectin spot-on was well tolerated by cats and highly effective for 12 weeks against ticks and fleas. Fluralaner plus moxidectin was non-inferior to fipronil for the proportion of ectoparasite-free and consistently superior to fipronil in controlling fleas.
Collapse
Affiliation(s)
- Nadja Rohdich
- MSD Animal Health Innovation GmbH, Zur Propstei, 55270 Schwabenheim, Germany
| | - Eva Zschiesche
- MSD Animal Health Innovation GmbH, Zur Propstei, 55270 Schwabenheim, Germany
| | - Oliver Wolf
- Loehlein & Wolf Vet Research, Maistrasse 69, 80337 Munich, Germany
| | | | - Thierry Pobel
- TPC Biomed, C/Los Betetas 12-4°D, 42002 Soria, Spain
| | | | - Rainer K. A. Roepke
- MSD Animal Health Innovation GmbH, Zur Propstei, 55270 Schwabenheim, Germany
| |
Collapse
|
32
|
Gopinath D, Meyer L, Smith J, Armstrong R. Topical or oral fluralaner efficacy against flea (Ctenocephalides felis) transmission of Dipylidium caninum infection to dogs. Parasit Vectors 2018; 11:557. [PMID: 30359284 PMCID: PMC6202868 DOI: 10.1186/s13071-018-3140-x] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2018] [Accepted: 10/10/2018] [Indexed: 11/10/2022] Open
Abstract
Background Dipylidium caninum is a common tapeworm of dogs contracted from ingestion of fleas containing the infective cysticercoid stage. Fluralaner is a systemically distributed isoxazoline class insecticide that delivers highly effective activity against fleas and ticks for up to 12 weeks after a single oral or topical treatment. This study evaluated the impact of this flea insecticidal efficacy on the transmission of D. caninum to dogs. Methods Dogs were weighed and treated with a cestocide and then randomly assigned to 3 groups of 8. Fluralaner was administered topically (at the commercial dose) to one group and orally to another group while the third received topically administered sterile water. All dogs were subsequently infested with about 100 D. caninum infected Ctenocephalides felis at 7, 14, 21, 28, 35, 42, 49, 56, 63, 70, 77 and 83 days after treatment. Visual proglottid inspections and counts were conducted daily from 35 to 113 days post-treatment. Post-treatment D. caninum incidence was calculated for each group and compared between treated and untreated groups. Results All 8 dogs in the placebo-treated group became infected with D. caninum while no shed proglottids were observed at any point during the post-treatment period from any dog in either fluralaner treated group. Conclusions The insecticidal efficacy of a single treatment of either orally or topically administered fluralaner prevented D. caninum transmission from infected fleas to susceptible dogs for up to 12 weeks following administration.
Collapse
Affiliation(s)
- Deepa Gopinath
- MSD Animal Health, 26 Talavera Rd, Macquarie Park, NSW, 2113, Australia
| | - Leon Meyer
- Clinvet International, Uitzich Road, Bainsvlei, Bloemfontein, 9338, South Africa
| | - Jehane Smith
- Clinvet International, Uitzich Road, Bainsvlei, Bloemfontein, 9338, South Africa
| | - Rob Armstrong
- Merck Animal Health, 2 Giralda Farms, Madison, NJ, 07940, USA.
| |
Collapse
|
33
|
Lavan R, Armstrong R, Burgio F, Tunceli K. Duration of annual canine flea and tick protection provided by dog owners in Spain. Parasit Vectors 2018; 11:458. [PMID: 30086779 PMCID: PMC6081898 DOI: 10.1186/s13071-018-3043-x] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2018] [Accepted: 07/30/2018] [Indexed: 12/11/2022] Open
Abstract
Background Doses of flea and tick medication acquired by dog owners over a 12 month period were determined from veterinary hospital transaction records in Spain. The number of months of flea and tick protection potentially obtained by dog owners prescribed fluralaner, a flea and tick medication with a 12 week re-dosing interval, was compared with months of flea and tick protection obtained by dog owners prescribed monthly oral or spot-on products. Prior studies in human and veterinary medicine have suggested that longer-acting medications benefit patients by providing improved adherence to provider recommendations. Results Dog owners took home, on average, significantly more months of protection when they obtained the 12 week duration product fluralaner (4.3 months) than they did when they obtained other flea and tick products providing 1 month of protection [3.24 months (oral), 2.9 months (spot-on)]. Many dog owners (46–64%) obtained only one dose of flea and tick product each year, regardless of the duration of protection offered by the product. Significantly more dog owners obtained 7–12 months of protection when they were prescribed fluralaner (15.7%) by their veterinarians compared with dog owners prescribed monthly flea and tick products [6.8% (oral), 8.3% (spot-on)]. Conclusion Veterinary prescription of fluralaner delivers more months of potential flea and tick protection as shown by dog owner acquisition of flea and tick medication. The use of a longer-acting medication requires the administration of fewer doses and may translate into better adherence to veterinary ectoparasite control recommendations.
Collapse
Affiliation(s)
- Robert Lavan
- Outcomes Research, MSD Animal Health, Center for Observational and Real-World Evidence, Merck & Co., Inc., Kenilworth, NJ, USA.
| | - Rob Armstrong
- MSD Animal Health, 2 Giralda Farms, Madison, NJ, USA
| | - Federica Burgio
- MSD Animal Health, Polígono Industrial El Montalvo. C/ Zeppelin, 6 - Parcela 38, 37008 Carbajosa de La Sagrada, Salamanca, España
| | - Kaan Tunceli
- Outcomes Research, MSD Animal Health, Center for Observational and Real-World Evidence, Merck & Co., Inc., Kenilworth, NJ, USA
| |
Collapse
|
34
|
Ranjan S, Young D, Sun F. A single topical fluralaner application to cats and to dogs controls fleas for 12 weeks in a simulated home environment. Parasit Vectors 2018; 11:385. [PMID: 29970135 PMCID: PMC6029119 DOI: 10.1186/s13071-018-2927-0] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2018] [Accepted: 06/01/2018] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Fluralaner (Bravecto®, Merck Animal Health, Madison, NJ, USA) is a novel isoxazoline that provides up to 12 weeks flea and tick control when administered orally to dogs. Two assessor-blinded studies, one in dogs, the other in cats evaluated the sustained efficacy of a topical fluralaner formulation against fleas in a simulated home environment (SHE). METHODS Animals were ranked and blocked into groups of two using flea counts completed 24 hours following Ctenocephalides felis infestations placed on dogs on Day -64, and on cats on Day -36. Within blocks animals were randomized to a treatment group, 10 animals per group, one group to receive fluralaner spot-on (minimum dose rate for dogs, 25 mg/kg; for cats, 40 mg/kg), the other to be a sham-treated control. Animals were then placed into their SHE, one animal per pen or cage and then infested with 100 C. felis at weekly intervals. Dogs were infested from Day -56 through -21 and cats on Days -28 and -21. Fleas were counted and removed from each dog and cat on Day -1. Study animals were then held in clean pens/cages until treatment on Day 0. One day later, after treatment, all animals were returned to their home environment (SHE). Additional 50-flea challenges were placed on each animal on Days 22, 50 and 78. Fleas were counted and replaced on all animals on Day 1 and weekly thereafter for 12 weeks. RESULTS Arithmetic mean counts in control-group animals exceeded 10 fleas at all post-treatment assessments except on Days 1, 7 and 14. All control-group animals remained infested at each assessment from Day or 28 through Day 84, thereby validating the challenge methodology. Fluralaner efficacy was 100% on all occasions except for 2 fleas found on 1 dog on Day 1, and 3 fleas on 1 dog on Day 14. One flea was recovered from 1 fluralaner treated cat on Day 1. There were no treatment-related adverse events. CONCLUSION A single application of a topical formulation of fluralaner is well tolerated and highly effective in the prevention of flea infestations of dogs and cats throughout the 12 weeks following treatment.
Collapse
Affiliation(s)
- Sivaja Ranjan
- Merck Animal Health, 2 Giralda Farm, Madison, NJ, 07940, USA.
| | - David Young
- David R Young, Young Veterinary Research Services, 213 South Roselawn Avenue, Turlock, CA, 95380, USA
| | - Fangshi Sun
- Merck Animal Health, 2 Giralda Farm, Madison, NJ, 07940, USA
| |
Collapse
|
35
|
Furutani S, Ihara M, Lees K, Buckingham SD, Partridge FA, David JA, Patel R, Warchal S, Mellor IR, Matsuda K, Sattelle DB. The fungal alkaloid Okaramine-B activates an L-glutamate-gated chloride channel from Ixodes scapularis, a tick vector of Lyme disease. INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE 2018; 8:350-360. [PMID: 29957333 PMCID: PMC6039357 DOI: 10.1016/j.ijpddr.2018.06.001] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/02/2017] [Revised: 05/31/2018] [Accepted: 06/03/2018] [Indexed: 11/29/2022]
Abstract
A novel L-glutamate-gated anion channel (IscaGluCl1) has been cloned from the black-legged tick, Ixodes scapularis, which transmits multiple pathogens including the agents of Lyme disease and human granulocytic anaplasmosis. When mRNA encoding IscaGluCl1 was expressed in Xenopus laevis oocytes, we detected robust 50-400 nA currents in response to 100 μM L-glutamate. Responses to L-glutamate were concentration-dependent (pEC50 3.64 ± 0.11). Ibotenate was a partial agonist on IscaGluCl1. We detected no response to 100 μM aspartate, quisqualate, kainate, AMPA or NMDA. Ivermectin at 1 μM activated IscaGluCl1, whereas picrotoxinin (pIC50 6.20 ± 0.04) and the phenylpyrazole fipronil (pIC50 6.90 ± 0.04) showed concentration-dependent block of the L-glutamate response. The indole alkaloid okaramine B, isolated from fermentation products of Penicillium simplicissimum (strain AK40) grown on okara pulp, activated IscaGluCl1 in a concentration-dependent manner (pEC50 5.43 ± 0.43) and may serve as a candidate lead compound for the development of new acaricides.
Collapse
Affiliation(s)
- Shogo Furutani
- Department of Applied Biological Chemistry, Faculty of Agriculture, Kindai University, 3327-204 Nakamachi, Nara 631-8505, Japan
| | - Makoto Ihara
- Department of Applied Biological Chemistry, Faculty of Agriculture, Kindai University, 3327-204 Nakamachi, Nara 631-8505, Japan
| | - Kristin Lees
- Neurosystems Section, Faculty of Life Sciences, University of Manchester, AV Hill Building, Oxford Road, Manchester M13 9PT, UK
| | - Steven D Buckingham
- Centre for Respiratory Biology, UCL Respiratory, Division of Medicine, University College London, Rayne Building, 5 University Street, London WC1E 6JF, UK
| | - Frederick A Partridge
- Neurosystems Section, Faculty of Life Sciences, University of Manchester, AV Hill Building, Oxford Road, Manchester M13 9PT, UK; Centre for Respiratory Biology, UCL Respiratory, Division of Medicine, University College London, Rayne Building, 5 University Street, London WC1E 6JF, UK
| | - Jonathan A David
- School of Biology, University of St Andrews, North Haug, St. Andrews, Fife, Scotland KY16 9ST, UK
| | - Rohit Patel
- Neurosystems Section, Faculty of Life Sciences, University of Manchester, AV Hill Building, Oxford Road, Manchester M13 9PT, UK; School of Life Sciences, University of Nottingham, University Park, Nottingham, NG7 2RD, UK
| | - Scott Warchal
- Neurosystems Section, Faculty of Life Sciences, University of Manchester, AV Hill Building, Oxford Road, Manchester M13 9PT, UK
| | - Ian R Mellor
- School of Life Sciences, University of Nottingham, University Park, Nottingham, NG7 2RD, UK
| | - Kazuhiko Matsuda
- Department of Applied Biological Chemistry, Faculty of Agriculture, Kindai University, 3327-204 Nakamachi, Nara 631-8505, Japan
| | - David B Sattelle
- Neurosystems Section, Faculty of Life Sciences, University of Manchester, AV Hill Building, Oxford Road, Manchester M13 9PT, UK; Centre for Respiratory Biology, UCL Respiratory, Division of Medicine, University College London, Rayne Building, 5 University Street, London WC1E 6JF, UK.
| |
Collapse
|
36
|
SUCCESSFUL TREATMENT OF GENERALIZED DEMODICOSIS IN RED-HANDED TAMARINS (SAGUINUS MIDAS) USING A SINGLE ADMINISTRATION OF ORAL FLURALANER. J Zoo Wildl Med 2018; 49:470-474. [DOI: 10.1638/2017-0218.1] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
|
37
|
Gomez SA, Curdi JL, Hernandez JAC, Peris PP, Gil AE, Velasquez RVO, Hernandez PO, Picado A. Phlebotomine mortality effect of systemic insecticides administered to dogs. Parasit Vectors 2018; 11:230. [PMID: 29622033 PMCID: PMC5887228 DOI: 10.1186/s13071-018-2820-x] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2017] [Accepted: 03/26/2018] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Zoonotic visceral leishmaniasis (ZVL) caused by Leishmania (Leishmania) infantum is an important disease in humans and dogs. Different mammal species are reservoirs but dogs are considered to be the main one. Phlebotomine sand flies are the proven vector. Four systemic insecticides approved for their use in dogs were previously selected based on their potential to be used in endemic countries as part of the control programs of ZVL. These insecticides are proved to be safe and effective against the on-label insects and parasites, but there is no information about their activity against phlebotomine sand flies. METHODS The phlebotomine mortality of four systemic insecticides in dogs was evaluated using two randomized clinical trials. For the first trial, thirty dogs were randomly allocated into five groups: four treatments and one control, of equal size. The treatments evaluated were: Guardian®SR, Elanco (moxidectin); Comfortis®, Elanco (spinosad); Bravecto®, Merck Animal Health (fluralaner); and NexGard®, Merial (afoxolaner). Blood from dogs was taken at days 2, 4, 21 and 31 post-treatment (trial 1). The compound that showed the highest efficacy was selected for a second trial (trial 2) with 20 dogs sampled at days 0, 2, 4, 7, 14, 18, 32, 39, 51 and 84 post-treatment. Membrane feeding bioassays with Phlebotomus papatasi were used to evaluate the phlebotomine mortality efficacy of the different treatments. Phlebotomine mortality was observed every 24 h following the membrane feeding during 5 days. A mixed model for a negative binomial logistic regression, and a Cox proportional hazard mixed model were used to estimate phlebotomine mortality due to different treatments. RESULTS Fluralaner was the only compound that showed significant phlebotomine mortality. Fluralaner maintained the phlebotomine mortality between 60-80% for 30 days after treatment. In trial 1 we found that fluralaner increased the risk of death by 1.9 times (95% CI: 1.02-3.6) and 1.7 times (95% CI: 1.09-2.6) at days 2 and 4 after treatment. The Cox model resulted in an increase of 1.47 (95% CI: 1.1-1.96) times in hazard risk at day 2 and 1.89 (95% CI: 1.35-2.45) at day 4 after treatment. In trial 2 we found that fluralaner increased the risk of death by 1.64 times (95% CI: 1.16-2.54) and 1.97 times (95% CI: 1.23-3.17) at days 14 and 32. The hazard risk was also increased by 1.92 (95% CI: 1.4-2.64) times at day 14 after treatment. Phlebotomine survival including all experimental days was significantly lower in the fluralaner group in both trials. CONCLUSIONS A single oral treatment of fluralaner in dogs induces phlebotomine mortality. Systemic insecticides in dogs should be considered as a potential preventive measure of ZVL.
Collapse
Affiliation(s)
- Sonia Ares Gomez
- ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain
| | - Javier Lucientes Curdi
- Department of Animal Pathology, Faculty of Veterinary Medicine at the University of Zaragoza, Zaragoza, Spain
| | | | - Paz Peris Peris
- Department of Animal Pathology, Faculty of Veterinary Medicine at the University of Zaragoza, Zaragoza, Spain
| | - Adriana Esteban Gil
- Department of Animal Pathology, Faculty of Veterinary Medicine at the University of Zaragoza, Zaragoza, Spain
| | | | - Paula Ortega Hernandez
- Department of Animal Pathology, Faculty of Veterinary Medicine at the University of Zaragoza, Zaragoza, Spain
| | - Albert Picado
- ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic-Universitat de Barcelona, Barcelona, Spain
| |
Collapse
|
38
|
Morita T, Momota Y, Mori A, Oda H, Ike K, Sako T. Successful treatment of refractory demodicosis and transient papules with a single dose of fluralaner in a dog with uncontrolled severe endocrine disease. J Vet Med Sci 2018. [PMID: 29515061 PMCID: PMC5938199 DOI: 10.1292/jvms.17-0274] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023] Open
Abstract
A 12-year-old female Shih-Tzu with hyperadrenocorticism and hypothyroidism developed
concurrent refractory generalized demodicosis that did not respond to doramectin
treatment. Although amitraz treatment was effective, the dog developed severe diabetes,
which resulted in the cessation of amitraz and trilostane. Attempts to control the
diabetes were unsuccessful, and its hyperadrenocorticism was left untreated, leading to
the recurrence of demodicosis. However, demodicosis went into complete remission with a
single dose of fluralaner. Transient erythematous papules appeared on the trunk three days
after the administration of fluralaner, but no other adverse reactions were noted. We
demonstrated that fluralaner is a potent treatment for demodicosis, and skin eruptions are
possible after the first dose of the drug.
Collapse
Affiliation(s)
- Tatsushi Morita
- Department of Veterinary Pathobiology, School of Veterinary Medicine, Faculty of Veterinary Science, Nippon Veterinary and Life Science University, 1-7-1 Kyonan-cho, Musashino, Tokyo 180-8602, Japan
| | - Yutaka Momota
- Department of Veterinary Nursing, School of Veterinary Nursing and Technology, Faculty of Veterinary Science, Nippon Veterinary and Life Science University, Musashino, Tokyo 180-8602, Japan
| | - Akihiro Mori
- Department of Veterinary Nursing, School of Veterinary Nursing and Technology, Faculty of Veterinary Science, Nippon Veterinary and Life Science University, Musashino, Tokyo 180-8602, Japan
| | - Hitomi Oda
- Department of Veterinary Nursing, School of Veterinary Nursing and Technology, Faculty of Veterinary Science, Nippon Veterinary and Life Science University, Musashino, Tokyo 180-8602, Japan
| | - Kazunori Ike
- Department of Veterinary Pathobiology, School of Veterinary Medicine, Faculty of Veterinary Science, Nippon Veterinary and Life Science University, 1-7-1 Kyonan-cho, Musashino, Tokyo 180-8602, Japan
| | - Toshinori Sako
- Department of Veterinary Nursing, School of Veterinary Nursing and Technology, Faculty of Veterinary Science, Nippon Veterinary and Life Science University, Musashino, Tokyo 180-8602, Japan
| |
Collapse
|
39
|
Duangkaew L, Larsuprom L, Anukkul P, Lekcharoensuk C, Chen C. A field trial in Thailand of the efficacy of oral fluralaner for the treatment of dogs with generalized demodicosis. Vet Dermatol 2018; 29:208-e74. [DOI: 10.1111/vde.12524] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/11/2017] [Indexed: 11/27/2022]
Affiliation(s)
- Lerpen Duangkaew
- Veterinary Teaching Hospital; Kasetsart University; 50 Ngamwongwan Road Chatuchak 10900 Thailand
| | - Lawan Larsuprom
- Veterinary Teaching Hospital; Kasetsart University; 50 Ngamwongwan Road Chatuchak 10900 Thailand
| | - Pojnicha Anukkul
- Veterinary Teaching Hospital; Kasetsart University; 50 Ngamwongwan Road Chatuchak 10900 Thailand
| | - Chalermpol Lekcharoensuk
- Veterinary Teaching Hospital; Kasetsart University; 50 Ngamwongwan Road Chatuchak 10900 Thailand
| | - Charles Chen
- Asian Veterinary Specialist Referral Center; 1F No.109 Section 4 Xin Yi road Taipei Taiwan
| |
Collapse
|
40
|
Cavalleri D, Murphy M, Seewald W, Drake J, Nanchen S. A randomized, controlled study to assess the efficacy and safety of lotilaner (Credelio™) in controlling ticks in client-owned dogs in Europe. Parasit Vectors 2017; 10:531. [PMID: 29089058 PMCID: PMC5664821 DOI: 10.1186/s13071-017-2478-9] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2017] [Accepted: 10/12/2017] [Indexed: 06/14/2024] Open
Abstract
BACKGROUND Oral administration of lotilaner flavoured chewable tablets (Credelio™, Elanco) to dogs has been shown to provide a rapid onset of killing activity of infesting ticks, with sustained efficacy for at least 35 days. A study was undertaken in Europe to confirm lotilaner's safety and anti-tick efficacy in client-owned dogs. METHODS In this assessor-blinded study, dogs were enrolled at 19 clinics in Germany, Hungary and Portugal. Qualifying households with no more than three dogs were randomized in an approximate 2:1 ratio to a lotilaner or fipronil/(S)-methoprene (FSM) (Frontline® Combo Spot-on, Merial) treatment group. One household dog with at least three live attached ticks was the primary dog. Treatments were dispensed Days 0, 28 (± 2) and 56 (± 2) for owner administration to all household dogs. Tick counts were performed on primary dogs Days 7 (± 1), and ±2 days on Days 14, 21, 28, 42, 56, 70 and 84; supplementary dogs were assessed for safety ± 2 days on Days 28, 56 and 84. Efficacy was assessed by comparing mean Day 0 live attached tick counts with subsequent counts. RESULTS The most frequently retrieved ticks were Ixodes ricinus, Dermacentor reticulatus and Rhipicephalus sanguineus (sensu lato), with Ixodes hexagonus also present. In the lotilaner group (n = 127) geometric mean tick count reductions were at least 98% from the first post-treatment visit (Day 7) through Day 56, when efficacy was 100%. For FSM (n = 68), efficacy remained at least 96% through Day 84, but at no point were all dogs free of live attached ticks. Mean counts in lotilaner-treated dogs were significantly lower than FSM-treated dogs on Days 7, 42, 70 and 84 (P < 0.05). Percent efficacy over all post-enrolment visits was 99.3 and 98.3% for lotilaner and FSM groups, respectively (t (190) = 2.23, P = 0.0268). Owners successfully administered all treatments, and both products were well-tolerated. CONCLUSION Under European field conditions, lotilaner flavoured chewable tablets administered monthly, were > 98% effective in eliminating live ticks from the first post-treatment assessment (Day 7) through Day 56 and maintained 100% of dogs tick-free on Days 70 and 84. Lotilaner was safe, providing superior tick control to FSM administered according to the same schedule.
Collapse
Affiliation(s)
| | - Martin Murphy
- Elanco Animal Health, Mattenstrasse 24a, 4058, Basel, Switzerland
| | - Wolfgang Seewald
- Elanco Animal Health, Mattenstrasse 24a, 4058, Basel, Switzerland
| | - Jason Drake
- Elanco Animal Health, 2500 Innovation Way, Greenfield, IN, 46140, USA.
| | - Steve Nanchen
- Elanco Animal Health, Mattenstrasse 24a, 4058, Basel, Switzerland
| |
Collapse
|
41
|
Mullens BA, Murillo AC, Zoller H, Heckeroth AR, Jirjis F, Flochlay-Sigognault A. Comparative in vitro evaluation of contact activity of fluralaner, spinosad, phoxim, propoxur, permethrin and deltamethrin against the northern fowl mite, Ornithonyssus sylviarum. Parasit Vectors 2017; 10:358. [PMID: 28768553 PMCID: PMC5541702 DOI: 10.1186/s13071-017-2289-z] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2017] [Accepted: 07/13/2017] [Indexed: 11/18/2022] Open
Abstract
Background Northern fowl mites (Ornithonyssus sylviarum) are obligate hematophagous ectoparasites of both feral birds and poultry, particularly chicken layers and breeders. They complete their entire life-cycle on infested birds while feeding on blood. Infestations of O. sylviarum are difficult to control and resistance to some chemical classes of acaricides is a growing concern. The contact susceptibility of O. sylviarum to a new active ingredient, fluralaner, was evaluated, as well as other compounds representative of the main chemical classes commonly used to control poultry mite infestations in Europe and the USA. Methods Six acaricides (fluralaner, spinosad, phoxim, propoxur, permethrin, deltamethrin) were dissolved and serially diluted in butanol:olive oil (1:1) to obtain test solutions used for impregnation of filter paper packets. A carrier-only control was included. Thirty adult northern fowl mites, freshly collected from untreated host chickens, were inserted into each packet for continuous compound exposure. Mite mortality was assessed after incubation of the test packets for 48 h at 75% relative humidity and a temperature of 22 °C. Results Adult mite LC50 /LC99 values were 2.95/8.09 ppm for fluralaner, 1587/3123 ppm for spinosad, 420/750 ppm for phoxim and 86/181 ppm for propoxur. Permethrin and deltamethrin LC values could not be calculated due to lack of mortality observed even at 1000 ppm. Conclusions Northern fowl mites were highly sensitive to fluralaner after contact exposure. They were moderately sensitive to phoxim and propoxur, and less sensitive to spinosad. Furthermore, the tested mite population appeared to be resistant to the pyrethroids, permethrin and deltamethrin, despite not being exposed to acaricides for at least 10 years. Electronic supplementary material The online version of this article (doi:10.1186/s13071-017-2289-z) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Bradley A Mullens
- Department of Entomology, University of California, Riverside, CA, 92521, USA.
| | - Amy C Murillo
- Department of Entomology, University of California, Riverside, CA, 92521, USA
| | - Hartmut Zoller
- MSD Animal Health Innovation GmbH, Schwabenheim, Germany
| | | | | | | |
Collapse
|
42
|
Loza A, Talaga A, Herbas G, Canaviri RJ, Cahuasiri T, Luck L, Guibarra A, Goncalves R, Pereira JA, Gomez SA, Picado A, Messenger LA, Bern C, Courtenay O. Systemic insecticide treatment of the canine reservoir of Trypanosoma cruzi induces high levels of lethality in Triatoma infestans, a principal vector of Chagas disease. Parasit Vectors 2017; 10:344. [PMID: 28724448 PMCID: PMC5518140 DOI: 10.1186/s13071-017-2278-2] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2017] [Accepted: 07/06/2017] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Despite large-scale reductions in Chagas disease prevalence across Central and South America, Trypanosoma cruzi infection remains a considerable public health problem in the Gran Chaco region where vector-borne transmission persists. In these communities, peridomestic animals are major blood-meal sources for triatomines, and household presence of infected dogs increases T. cruzi transmission risk for humans. To address the pressing need for field-friendly, complementary methods to reduce triatomine infestation and interrupt T. cruzi transmission, this study evaluated the systemic activity of three commercial, oral, single dose insecticides Fluralaner (Bravecto®), Afoxolaner (NexGard®) and Spinosad (Comfortis®) in canine feed-through assays against Triatoma infestans, the principal domestic vector species in the Southern Cone of South America. METHODS Twelve healthy, outbred dogs were recruited from the Zoonosis Surveillance and Control Program in Santa Cruz, Bolivia, and randomized to three treatment groups, each containing one control and three treated dogs. Following oral drug administration, colony-reared second and third stage T. infestans instars were offered to feed on dogs for 30 min at 2, 7, 21, 34 and 51 days post-treatment. RESULTS Eighty-five per cent (768/907) of T. infestans successfully blood-fed during bioassays, with significantly higher proportions of bugs becoming fully-engorged when exposed to Bravecto® treated dogs (P < 0.001) for reasons unknown. Exposure to Bravecto® or NexGard® induced 100% triatomine mortality in fully- or semi-engorged bugs within 5 days of feeding for the entire follow-up period. The lethality effect for Comfortis® was much lower (50-70%) and declined almost entirely after 51 days. Instead Comfortis® treatment resulted in substantial morbidity; of these, 30% fully recovered whereas 53% remained morbid after 120 h, the latter subsequently unable to feed 30 days later. CONCLUSIONS A single oral dose of Fluralaner or Afoxolaner was safe and well tolerated, producing complete triatomine mortality on treated dogs over 7.3 weeks. While both drugs were highly efficacious, more bugs exposed to Fluralaner took complete blood-meals, and experienced rapid knock-down. Coupled with its longer residual activity, Fluralaner represents an ideal insecticide for development into a complementary, operationally-feasible, community-level method of reducing triatomine infestation and potentially controlling T. cruzi transmission, in the Gran Chaco region.
Collapse
Affiliation(s)
- Ariel Loza
- Facultad de Ciencias Veterinarias, Universidad Autonóma Gabriel René Moreno (UAGRM), Santa Cruz, Bolivia
| | - Adrianna Talaga
- University of Warwick, Gibbet Hill Campus, Coventry, CV4 7AL, UK
| | - Gladys Herbas
- Facultad de Ciencias Veterinarias, Universidad Autonóma Gabriel René Moreno (UAGRM), Santa Cruz, Bolivia
| | - Ruben Jair Canaviri
- Facultad de Ciencias Veterinarias, Universidad Autonóma Gabriel René Moreno (UAGRM), Santa Cruz, Bolivia
| | - Thalia Cahuasiri
- Facultad de Ciencias Veterinarias, Universidad Autonóma Gabriel René Moreno (UAGRM), Santa Cruz, Bolivia
| | - Laura Luck
- Facultad de Ciencias Veterinarias, Universidad Autonóma Gabriel René Moreno (UAGRM), Santa Cruz, Bolivia
| | - Alvaro Guibarra
- Facultad de Ciencias Veterinarias, Universidad Autonóma Gabriel René Moreno (UAGRM), Santa Cruz, Bolivia
| | - Raquel Goncalves
- University of Warwick, Gibbet Hill Campus, Coventry, CV4 7AL, UK
| | - Juan Antonio Pereira
- Facultad de Ciencias Veterinarias, Universidad Autonóma Gabriel René Moreno (UAGRM), Santa Cruz, Bolivia
| | - Sonia A Gomez
- ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clinic - Universitat de Barcelona, Rosello 132, 08036, Barcelona, Spain
| | - Albert Picado
- ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clinic - Universitat de Barcelona, Rosello 132, 08036, Barcelona, Spain
| | | | - Caryn Bern
- University of California-San Francisco, 550 16th St, 94158, San Francisco, CA, USA
| | - Orin Courtenay
- University of Warwick, Gibbet Hill Campus, Coventry, CV4 7AL, UK
| |
Collapse
|
43
|
Romero C, Sheinberg Waisburd G, Pineda J, Heredia R, Yarto E, Cordero AM. Fluralaner as a single dose oral treatment for Caparinia tripilis
in a pygmy African hedgehog. Vet Dermatol 2017; 28:622-e152. [DOI: 10.1111/vde.12465] [Citation(s) in RCA: 16] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/25/2017] [Indexed: 11/29/2022]
Affiliation(s)
- Camilo Romero
- Centro Universitario UAEM Amecameca; Km. 2.5 Amecameca-Ayapango Highway 56900 Amecameca de Juarez estado de Mexico Mexico
| | - Galia Sheinberg Waisburd
- Centro Veterinario México; Calle Cincinnati #22, Benito Juárez, Cd de los Deportes 03710 Ciudad de México CDMX Mexico
| | - Jocelyn Pineda
- Centro Universitario UAEM Amecameca; Km. 2.5 Amecameca-Ayapango Highway 56900 Amecameca de Juarez estado de Mexico Mexico
| | - Rafael Heredia
- Centro Universitario UAEM Amecameca; Km. 2.5 Amecameca-Ayapango Highway 56900 Amecameca de Juarez estado de Mexico Mexico
| | - Enrique Yarto
- Centro Veterinario México; Calle Cincinnati #22, Benito Juárez, Cd de los Deportes 03710 Ciudad de México CDMX Mexico
| | - Alberto M. Cordero
- VETDERM: Dermatología Veterinaria Especializada; Moderna; Av Niños Héroes 1665 44190 Guadalajara Jalisco México
| |
Collapse
|
44
|
Gomez SA, Picado A. Systemic insecticides used in dogs: potential candidates for phlebotomine vector control? Trop Med Int Health 2017; 22:755-764. [PMID: 28326655 DOI: 10.1111/tmi.12870] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Zoonotic visceral leishmaniasis (ZVL) is a public health problem endemic in some countries. Current control measures, in particular culling infected dogs, have not reduced ZVL incidence in humans. We evaluated the use of five systemic insecticides (spinosad, fluralaner, afoxolaner, sarolaner and moxidectin) currently used in dogs for other purposes (e.g. tick, flea control) in controlling ZVL transmission. The anti-phlebotomine capacity of these compounds confirmed in experimental studies makes their use in ZVL control programmes very promising. Limitations and benefits of using this new control tool are compared to current practices.
Collapse
Affiliation(s)
| | - Albert Picado
- Barcelona Institute for Global Health, Barcelona, Spain
| |
Collapse
|
45
|
Meadows C, Guerino F, Sun F. A randomized, blinded, controlled USA field study to assess the use of fluralaner topical solution in controlling canine flea infestations. Parasit Vectors 2017; 10:36. [PMID: 28103945 PMCID: PMC5248447 DOI: 10.1186/s13071-017-1971-5] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2016] [Accepted: 01/05/2017] [Indexed: 11/18/2022] Open
Abstract
Background Orally administered fluralaner effectively controls fleas and ticks on dogs for 12 weeks. This study evaluates the flea control efficacy achieved with topically applied fluralaner in dogs. Methods This investigator-blinded, multi-center randomized, positive controlled study evaluated flea control efficacy in dogs following a single owner-applied treatment of topical fluralaner. A positive control group received three treatments, at 4-week intervals, of a commercial formulation of fipronil/(S)-methoprene. All dogs in households randomized to the fluralaner group were dispensed an initial treatment at enrollment and a second treatment at week 12 for an additional 3-week observation of treatment safety. Households with up to five healthy dogs, all at least 12 weeks of age and weighing at least 2 kg (4.4 lb), were randomized in a ratio of 3:1 of fluralaner to positive control. Within households, one primary dog with at least 10 live fleas at enrollment was randomly selected. Flea counts were performed on all primary dogs every 4 weeks through week 12. Efficacy measurement was based on reduction from baseline flea counts. Treatment was considered effective if geometric mean live flea count reductions at weeks 4, 8, and 12 were 90% or greater and significantly different from counts at enrollment. In addition, for each time point the arithmetic mean live flea counts, the efficacy based on arithmetic means, the number and percentage of dogs with at least a 90% reduction in flea count, and the number and percentage of flea free dogs were calculated. Statistical comparisons were also made between treatment groups. Results At 12 sites, across 10 states, 121 households (221 dogs) were randomized to receive fluralaner and 44 households (100 dogs) were randomized to receive the positive control. Fluralaner was demonstrated to be significantly effective (all P ≤ 0.0001) at 4 weeks (99.8% reduction), 8 weeks (99.9%), and 12 weeks (99.9%). The positive control was significantly different from baseline (all P ≤ 0.0001) and showed a reduction of 81.2% at 4 weeks and was effective at 8 weeks (90.3%) and 12 weeks (93.0%). Arithmetic mean flea count reductions for the fluralaner group at 4, 8, and 12 weeks were 99.8, 99.9, and 99.9%, respectively. For the positive control, arithmetic mean flea count reductions were 58.8, 75.3, and 80.8% at 4, 8, and 12 weeks, respectively. No treatment-related serious adverse events were reported in either group. Conclusions Owner-applied topical fluralaner treatment was safe in dogs and provided ≥ 99.8% flea control efficacy for 12 weeks.
Collapse
|
46
|
Meadows C, Guerino F, Sun F. A randomized, blinded, controlled USA field study to assess the use of fluralaner topical solution in controlling feline flea infestations. Parasit Vectors 2017; 10:37. [PMID: 28103942 PMCID: PMC5248512 DOI: 10.1186/s13071-017-1972-4] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2016] [Accepted: 01/05/2017] [Indexed: 11/12/2022] Open
Abstract
Background Fleas are a common ectoparasite of domestic cats and there is a need for novel treatments that improve feline flea control. Methods This investigator-blinded, multi-center randomized, positive-controlled study evaluated the flea control in cats provided by a single owner-applied treatment with a fluralaner topical formulation compared with a positive control. Households with up to five healthy cats, all at least 12 weeks of age and weighing at least 1.2 kg (2.6 lb), were randomized in an approximate 3:1 ratio of fluralaner to positive control. All cats in households randomized to the positive control group were dispensed three treatments, at 4-week intervals, of a commercial formulation of fipronil/(S)-methoprene. All cats in households randomized to the fluralaner group were dispensed an initial treatment at enrollment and a second treatment at week 12 for an additional 3-week observation of treatment safety. One primary cat with at least five live fleas at enrollment was randomly selected within each household. Flea counts were performed on all primary cats at 4-week intervals through week 12. Efficacy measurement was based on reduction in flea counts from baseline. Treatment was considered effective at weeks 4, 8 and 12 if mean live flea count reductions were 90% or greater and statistically significantly different (P ≤ 0.05) from counts at enrollment. Results In 18 investigational veterinary clinics across 11 USA states, 116 households (224 cats) were randomized to receive topical fluralaner and 45 households (87 cats) were randomized to the fipronil-methoprene combination. Fluralaner was demonstrated to be effective at 4 weeks (99.1% flea count reduction), 8 weeks (99.5%), and 12 weeks (99.0%), and all reductions were significantly different from the enrollment count (all P < 0.0001). The fipronil-methoprene combination was < 90% effective at each post-treatment assessment, with peak efficacy of 75.4% at 12 weeks (all P < 0.0001). No treatment-related serious adverse events were reported in either group. Conclusions Owner-applied fluralaner topical treatment was safe in cats and was highly effective in killing fleas over the subsequent 12 weeks.
Collapse
|
47
|
White WH, Riggs KL, Totten ML, Snyder DE, McCoy CM, Young DR. Initial evaluations of the effectiveness of spinetoram as a long-acting, oral systemic pulicide for controlling cat flea (Ctenocephalides felis) infestations on dogs. Vet Parasitol 2016; 233:25-31. [PMID: 28043384 DOI: 10.1016/j.vetpar.2016.11.018] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2016] [Revised: 11/14/2016] [Accepted: 11/19/2016] [Indexed: 11/26/2022]
Abstract
Spinetoram is a semi-synthetic, spinosyn class natural product derived from fermentation by the actinomycete, Saccharopolyspora spinosa. Based on LD50 (50% lethal dose) values against adult cat fleas (Ctenocephalides felis) using an in vitro contact assay, spinetoram was approximately 4-fold more potent than spinosad. Subsequently, two parallel-arm, randomized block design laboratory studies were conducted to evaluate the effectiveness of orally administered spinetoram against experimental C. felis infestations on dogs, when administered as a single dose or multiple doses over a 6-12h interval. In the first study, 16 mixed-breed dogs were allocated to two treatment groups of eight dogs each, based on pre-treatment flea retention rates: negative (placebo) control; and a single dose of spinetoram at 30mg/kg. In the second study, 32 mixed- and pure-breed dogs were allocated to four treatments groups of eight dogs each, based on pre-treatment flea retention rates: negative (placebo) control; a single dose of 60mg/kg; three sequential 20mg/kg oral doses evenly administered over a 6h period; and three sequential 20mg/kg oral doses evenly administered over a 12h period. In both studies, treatments were administered to dogs in a fed state in order to enhance absorption of spinetoram. Therapeutic efficacy was assessed 24h after treatment and persistent efficacy was assessed 48h after each subsequent flea infestation. The duration of effectiveness was assessed at approximate weekly intervals beginning on Day 5 through Day 56 in the first study, or through Day 105 in the second study. In both studies, treatment efficacy was ≥99% (geometric means) through 44 d, with ≥99% efficacy continuing through 72 d for all three treatments in the second study. Efficacy remained ≥90% for at least 8 weeks with a single 30mg/kg dose; through 13 weeks with three sequential 20mg/kg doses; and through 15 weeks with a single 60mg/kg dose. For all time points and in both studies, spinetoram-treated groups had significantly fewer live fleas relative to their respective negative control group (p<0.05). The pharmacokinetic profile in dogs revealed that the mean plasma concentration of spinetoram required for effectiveness against fleas was maintained for at least 3 months regardless of whether the 60mg/kg total body dose was administered as a single bolus or in three sequential 20mg/kg doses administered over a 6-12h period of time. The results of preliminary in vitro and in vivo studies demonstrate that orally administered spinetoram was well tolerated, and provides long lasting effectiveness against C. felis infestations on dogs.
Collapse
Affiliation(s)
- W Hunter White
- Elanco Animal Health, A Division of Eli Lilly & Company, Greenfield, IN, USA
| | - Kari L Riggs
- Elanco Animal Health, A Division of Eli Lilly & Company, Greenfield, IN, USA
| | - Michelle L Totten
- Elanco Animal Health, A Division of Eli Lilly & Company, Greenfield, IN, USA
| | - Daniel E Snyder
- Elanco Animal Health, A Division of Eli Lilly & Company, Greenfield, IN, USA.
| | - Christine M McCoy
- Elanco Animal Health, A Division of Eli Lilly & Company, Greenfield, IN, USA
| | - David R Young
- Young Veterinary Research Services (YVRS), Turlock, CA, USA
| |
Collapse
|
48
|
Romero C, Heredia R, Pineda J, Serrano JA, Mendoza GD, Trápala P, Cordero AM. Efficacy of fluralaner in 17 dogs with sarcoptic mange. Vet Dermatol 2016; 27:353-e88. [DOI: 10.1111/vde.12363] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/22/2016] [Indexed: 11/27/2022]
Affiliation(s)
- Camilo Romero
- Centro Universitario UAEM Amecameca Universidad Autónoma del Estado de México Carretera Amecameca‐Ayapango Km 2.5 Amecameca de Juárez CP 56900 Estado de México México
| | - Rafael Heredia
- Doctorado en Ciencias Agropecuarias y Recursos Naturales Universidad Autónoma del Estado de México kilometro 14.5 carretera Toluca‐Atlacomulco desviación a Tlachalo El Cerrillo Piedras Blancas Toluca 50200 Estado de México México
| | - Jocelyn Pineda
- Centro Universitario UAEM Amecameca Universidad Autónoma del Estado de México Carretera Amecameca‐Ayapango Km 2.5 Amecameca de Juárez CP 56900 Estado de México México
| | - Jonathan A. Serrano
- Licenciatura de Medicina Veterinaria y Zootecnia Centro Universitario UAEM Amecameca Universidad Autónoma del Estado de México Carretera Amecameca‐Ayapango Km 2.5 Amecameca de Juárez 56900 Estado de México México
| | - Germán D. Mendoza
- Universidad Autónoma Metropolitana Unidad Xochimilco Calzada del Hueso 1100 Coyoacan 04960 Mexico DF México
| | - Porfirio Trápala
- Clinica Veterinaria Alhaurin Río Panuco No. 2424 Colonia México Monterrey 64740 NL México
| | - Alberto M. Cordero
- Veterinaria Dermatología Veterinaria Especializada Argentina No. 690 colonia moderna Guadalajara 44190 Jalisco México
| |
Collapse
|
49
|
Pfister K, Armstrong R. Systemically and cutaneously distributed ectoparasiticides: a review of the efficacy against ticks and fleas on dogs. Parasit Vectors 2016; 9:436. [PMID: 27502490 PMCID: PMC4977707 DOI: 10.1186/s13071-016-1719-7] [Citation(s) in RCA: 42] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2016] [Accepted: 07/24/2016] [Indexed: 11/18/2022] Open
Abstract
Acaricidal (tick) and insecticidal (flea) efficacy of systemically and cutaneously distributed ectoparasiticide products for dogs are compared based on permethrin and fluralaner as representative molecules. Results of efficacy studies against fleas and ticks are reviewed that show generally good to excellent results. Both externally and systemically distributed treatments have benefits and weaknesses in potentially preventing pathogen transmission by these arthropod vectors. Four general properties are considered related to the goal of providing optimal reduction in the risk of vector-borne pathogen transmission. These are:Owner adherence to the recommended treatment protocol; Rapid onset of activity following administration; Uniform efficacy over all areas of the treated dog at risk for parasite attachment; Maintenance of high efficacy throughout the retreatment interval.
In considering these four factors, a systemically distributed acaricide can offer an option that is at least as effective as a cutaneously administered acaricide with regard to the overall goal of reducing the risk of vector-borne pathogen transmission.
Collapse
Affiliation(s)
- Kurt Pfister
- Parasite Consulting GmbH, Wendschatzstrasse 8, CH-3006, Berne, Switzerland.
| | - Rob Armstrong
- MSD Animal Health, 2 Giralda Farms, Madison, NJ, 07940, USA
| |
Collapse
|
50
|
Six RH, Young DR, Myers MR, Mahabir SP. Comparative speed of kill of sarolaner (Simparica™ Chewables) and fluralaner (Bravecto(®)) against induced infestations of Amblyomma americanum on dogs. Parasit Vectors 2016; 9:399. [PMID: 27430425 PMCID: PMC4950088 DOI: 10.1186/s13071-016-1684-1] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2016] [Accepted: 07/05/2016] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND The lone star tick, Amblyomma americanum, infests dogs and cats in North America and transmits the pathogens Ehrlichia chaffeensis and Ehrlichia ewingii, which cause monocytic and granulocytic ehrlichiosis in dogs and humans, and Cytauxzoon felis which causes cytauxzoonosis in cats. A parasiticide's speed of kill is important to minimize the direct deleterious effects [related to blood-feeding] of tick infestation and reduce the risk of transmission of tick-borne pathogens. In this study the speed of kill of sarolaner (Simparica™ Chewables) administered monthly for 3 months against A. americanum on dogs was evaluated and compared with a single dose of fluralaner (Bravecto(®)) for 13 weeks. METHODS Based on pretreatment tick counts, 24 dogs were randomly allocated to treatment with placebo or sarolaner at the label rate (2 to 4 mg/kg) on Days 0, 30 and 60 or with fluralaner (25 to 56 mg/kg) once according to manufacturer's instructions on Day 0. Dogs were examined and live ticks counted at 8, 12, and 24 h after treatment and subsequent re-infestations on Days 14, 28, 42, 58, 76 and 90. Acaricidal efficacy was determined at each time point relative to counts for placebo dogs. RESULTS Monthly oral doses of sarolaner provided > 95 % efficacy within 24 h of treatment, and consistently provided > 70 % efficacy against subsequent re-infestations with ticks within 24 h over the entire treatment period. Significantly more live ticks were recovered from fluralaner-treated dogs than from sarolaner-treated dogs at 24 h after re-infestation from Day 42 onwards. At 24 h, efficacy of fluralaner was ≤ 20 % from Day 42 to the end of the study on Day 90. There were no adverse reactions to treatment. CONCLUSIONS In this controlled laboratory evaluation, monthly treatment with sarolaner provided consistent efficacy against A. americanum with > 70 % of ticks killed within 24 h after a single oral dose over the duration of the study. Monthly treatment with sarolaner consistently killed significantly more ticks within 24 h than a single dose of fluralaner from 6 weeks after initial treatment.
Collapse
Affiliation(s)
- Robert H Six
- Zoetis, Veterinary Medicine Research and Development, 333 Portage St., Kalamazoo, MI, 49007, USA.
| | | | - Melanie R Myers
- Zoetis, Veterinary Medicine Research and Development, 333 Portage St., Kalamazoo, MI, 49007, USA
| | - Sean P Mahabir
- Zoetis, Veterinary Medicine Research and Development, 333 Portage St., Kalamazoo, MI, 49007, USA
| |
Collapse
|